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Introduction
This thesis explored gene association networks of the radiation response of normal
and tumor cells in a therapeutic dose range. These networks were derived from
time-course mRNA expression data that required bioinformatic strategies for the
analysis of high-dimensional data sets. The gene association networks of sensitive
and resistant cells were compared. The novel bioinformatic approach as well as the
results from the network reconstructions were published in two peer-reviewed jour-
nals and built the basis for this thesis.
Radiation therapy and head and neck cancer
Radiation therapy alone or in combination with surgery and/or drug therapy serves
as a fundamental tool for cancer treatments. About 50% of all cancer patients re-
ceive curative radiation therapy during their disease [1–3]. However, despite its high
effectiveness, radio(chemo)therapy can fail to eradicate all of the clonogenic cancer
cells resulting in the relapse of the disease.
Radiotherapy is usually divided in a number of daily fractions to reach the total
dose that is needed to treat a particular tumor type which is usually in the range of
50-70 Gy in the case of head and neck squamous cell carcinomas (HNSCC). Impor-
tantly, the total dose is applied in a fractionated way (usually 1.8-2 Gy per day)
which affects cellular key processes including DNA repair, cell cycle redistribution,
repopulation of cells continuing to proliferate and cell reoxygenation [4]. Owing to
the fact that the surviving cancer cells are able to regenerate the tumor, repopula-
tion is one of the most common reasons for the failure of conventional fractionated
courses of radiation therapy [5–7]. Additionally, there are some evidences that the
repopulating tumor cells acquire radioresistance which limits the effectiveness of the
radiation therapy [8]. Further, it is well known that tumor subpopulations in hy-
poxic areas are more radioresistant and thereby are critical to target for increased
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therapeutic benefits [9]. Reoxygenation between dose fractions is therefore believed
to improve the efficacy of radiotherapy.
Another important factor for therapy success is the intrinsic radiosensitivity of both
tumor and normal cells [10]. The intrinsic radiosensitivity of cells describes the
phenomenon that cells respond differently to radio(chemo)therapy a priori, influ-
encing thereby the overall outcome of the therapy. There is a strong link between
intrinsic radiosensitivity and genetic instability of different tumors leading to diverse
responses even among tumors of the same histopathology [11]. For this reason, iden-
tification of altered signaling pathways involved in the regulation of cell cycle, cell
proliferation, DNA response or apoptotic processes might offer the possibility for
stratification of poorly responding patients and for personalization of the treatment
based on individual features of the tumors. Among different cancers, intrinsic ra-
dioresistance has been shown as one of the main reasons of HNSCC recurrence [12].
In Europe, HNSCC develop in approx. 139,000 cases per year with an estimated
survival rate of 40% at 5 years after therapy [13]. They originate from the oral
cavity, nasopharynx, oropharynx, hypopharynx, or larynx [14]. The most important
risk factors include tobacco use, alcohol use, poor oral health and infection with
high-risk human papilloma viruses [15–17]. Moreover, HNSCC are very heterogenous
in terms of therapy response. Besides, poor prognosis of HNSCC patients is often
associated with radioresistance [18]. Therefore, it is of special interest to investigate
the molecular mechanisms of HNSCC in order to identify new potential biomarkers
of radioresistance and novel therapeutic targets.
Radiation response in normal and tumor tissues
Despite substantial progress in radiotherapy due to the implementation of advanced
medical imaging, precise radiation therapy planning, more accurate tumor target-
ing and development of radiation delivery methods combined with computational
technology the radiation response of normal and tumor tissues remains the limiting
factor in radiation treatments [19]. Normal tissue responses to ionizing radiation
vary greatly between patients. Approximately 5-10% of cancer patients develop
severe side effects to external radiotherapy in normal tissue within the treatment
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area [20]. The side effects of radiotherapy on normal tissue are classified into acute
effects, late effects and secondary cancer induction. Early effects appear during or
directly after radiotherapy and manifest erythema and desquamation of the exposed
skin and mucosa. Most severe skin and mucosa reactions are seen when radiother-
apy is applied in combination with chemotherapy such as cisplatin, methotrexate
or actinomycin D. Late effects such as fibrosis, anemia and telangiectasia develop
months or years after the end of treatment. Moreover, many organs including heart,
spinal cord, brain, kidneys, liver and lung exhibit high radiation sensitivity [21, 22].
In principle, acute or early effects of radiation can be modified by changing the in-
tensity of the treatment. However, up to 70% of the patient and treatment related
factors influencing the intraindividual variability of radiation side effects remain
unknown [23]. Turesson et al. suggested that the unexplained variability might be
associated with individual cellular radiation sensitivity determined by genetic and
epigenetic variation [23]. Hence, individual radiation sensitivity became an impor-
tant therapeutic aspect determining the success of radiotherapy and the ability to
modulate patient’s radiosensitivity is prerequisite to improve radiotherapy outcome.
For HNSCC it was proposed that fractionated radiation might eradicate radiosen-
sitive cells whereas the radioresistant ones remain largely untouched and therefore,
the recurrent tumors mostly consist of radioresistant cells [18, 24]. Although sev-
eral different mechanisms causing radioresistance have been suggested and exten-
sively studied, the underlying molecular mechanisms remain mostly unknown [25].
To date, three main pathways are known to be associated with radioresistance of
HNSCC - EGFR, PI3K/Akt/mTOR and the p53 signaling cascades [18, 26].
However, considering poor overall survival rates for radio(chemo)therapy-treated
HNSCC patients it is important to unravel the molecular mechanisms driving ra-
dioresistance in order to identify new targets for the modulation of therapeutic re-
sponse.
Determination of radiation response
The radiation response of normal and HNSCC cells can be measured by determining
cell survival or metabolic activity after irradiation. Cell survival is usually deter-
mined by the clonogenic (colony formation) assay, which is an in vitro cell survival
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assay based on the single cell capability to proliferate and develop a colony. The re-
lationship between applied radiation doses and proportion of survived cells measured
as colonies is described by dose-survival curves [27]. Although the colony forming
assay was initially introduced for studying the effects of ionizing radiation on cells,
nowadays this technique is widely used to examine the effects of different drugs and
chemicals that can be considered for clinical applications [28].
The clonogenic assay has been shown to be a reliable method for the detection of
radiation sensitive adherent cell lines, but is inconvenient for cells growing in sus-
pension such as the lymphoblastoid cells [29]. In such cases the metabolic activity
of mitochondria can be used as an indicator of cell viability. The principle of the
so-called WST-1 assay is based on the reduction of the water-soluble tetrazolium
salt WST-1 to formazan by cellular dehydrogenases. The concentration of generated
dark yellow colored formazan directly correlates with the number of viable cells and
therefore, the number of viable cells can be assessed by measuring the absorbance
at 420-480 nm [30].
The described approaches reflect either short-term (metabolic activity) or long-term
(survival) effects of irradiation, the latter of which is commonly accepted as a "gold
standard" to determine cellular radiation response.
Signaling pathways associated with radiation response
DNA is the main cellular target for radiation-induced cancer cell death. Ionizing ra-
diation induces a variety of DNA damages, including sugar and base modifications,
oxidized base damage, abasic sites, single strand breaks (SSBs), double strand breaks
(DSBs), DNA interstrand cross-links, DNA-proteins cross-links or locally multiply
damaged sites [31–34]. The DNA damage repair is crucial to genome integrity and
failures in repair have large impact on cell survival after irradiation. Therefore,
DNA damage response mechanisms represent very important elements of radiation
response.
The first phase of DNA damage response involves the phosphorylation and activation
of ATM and ATR kinases, which are responsible for controlling of various down-
stream signaling pathways [35, 36]. One of these pathways is involved in the regula-
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tion of the p53 protein activity. The p53 is one of the most important stress-induced
proteins and one of the main cell cycle regulators. Phosphorylation of p53 by ATM
or ATR leads to the stabilization of this protein by dissociation from MDM2 and
its accumulation in the nucleus. Depending on the phosphorylation site, activation
of the p53 protein may lead to cell cycle arrest or to apoptosis [37]. After cell cycle
arrest, DSBs are repaired mainly by non-homologous end-joining (NHEJ) and ho-
mologous recombination (HR). If the DNA damage is repaired, the cell will continue
to divide, otherwise inhibition of the cell proliferative ability may result in cell death
or permanent cell cycle arrest, i.e. senescence [38].
Apoptosis and mitotic catastrophe next to autophagy and necrosis are the major and
extensively studied radiation-induced forms of cell death [39–41]. However, despite
the diverse cell death options, cells developed a stress-induced senescence mechanism
to bypass the persistence of radiation-induced DNA damage and avoid possible can-
cer induction [42]. Regardless of the fact that senescent cells lost the proliferation
capability, they remain metabolically active and thereby cannot be considered as
dead [43]. Although it is obvious that cancer cell death is a desirable effect of radi-
ation therapy, it is not clear weather senescence has a positive or negative influence
on the tumor treatment. On the one hand side, cancer cells that undergo senescence
may secret the so-called senescence-associated secretory phenotype factors (SASP),
which leads to aggregation of immune cells and activation of an antitumor adaptive
immune response. Aggregated immune cells can target transformed or damaged cells
and thereby positively contribute to the tumor therapy [44–46]. On the other hand
side, the recruitment of immune cells can lead to sustained inflammation and persist-
ing senescence resulting in the induction of cancer or other inflammation-related dis-
eases [47–49]. Continuous senescence can damage local cell environment and thereby
stimulate angiogenesis and tumor progression [50–53]. Interestingly, Tsai et al. have
reported that the induction of senescence in tumor surrounding normal tissue may
increase radiation tolerance or even lead to radioresistance of the tumor [54]. More-
over, recent studies have shown that senescent tumor cells are dormant and might be
awaken some time after therapy [42]. Thus, senescence may in some circumstances
impose negative effects on the tumor radiotherapy and it might be beneficial to pre-
vent senescence or senescence-associated events in order to avoid acquired radiore-
sistance in tumor cells.
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The epidermal growth factor receptor (EGFR) pathway is another pathway affected
by ionizing radiation. Ionizing radiation can simulate the process of ligand binding
to EGFR and lead to dimerization of the receptor and subsequent activation by
autophosphorylation [55]. Activated EGFR initiates the expression of cyclin D1,
iNOS and B-MYB promoting cell cycle progression and proliferation [55–57]. In re-
sponse to ionizing radiation EGFR, particularly in heterodimers with ERBB2, can
act anti-apoptotically by transcriptional activation of the anti-apoptotic BCL2L1
gene. Furthermore, EGFR/ERBB2 heterodimers lead to activation of the PI3K/Akt1
pathway, which results in phosphorylation of cell cycle and apoptosis regulatory pro-
teins including IKK and mTOR [58, 59]. Activated by phosphorylation IKK sub-
sequently phosphorylates IkB causing the dissociation of NFκB from IkB. Transloca-
tion of the NFκB to the nucleus induces transcription of the anti-apoptotic genes [60].
The activation of mTOR kinase stimulates cell cycle progression, promotes cell sur-
vival and inhibits autophagy [61]. Moreover, EGFR may lead to a constant stimu-
lation of the RAS/RAF/MAPK pathway, which for several cancers has been linked
with radiation resistance [62–65]. Constantly activated or mutated RAS protein
triggers not only the pro-proliferative MAPK pathway but also the pro-survival
PI3K/Akt1 pathway [62].
Knowledge of the significance of cellular processes affected by ionizing radiation con-
tributes to the development of strategies, which aim to improve radiation therapy
outcome.
Strategies for modulation of radiation response
Strategies to improve radiotherapy outcome intend to increase the tumor response
or to decrease the response of normal tissue. Several different approaches including
inhibition of DNA repair mechanisms, cell death induction or suppression of survival
pathways have been followed in translational radiotherapy research to modulate tu-
mor response to ionizing radiation. Other strategies employ drugs that act as ra-
dioprotectors by preventing normal tissues from radiation damage without affecting
tumor radiosensitivity.
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Prophylactic, mitigators and therapeutic agents are the three types of normal tis-
sue radiation responses modifiers [66]. Prophylactic or protector agents are given
before the radiotherapy and include free radical scavengers, inhibitors of p53 and
antioxidant mediators that prevent from initialization of radiochemical events, early
apoptotic cell death and inflammation. Mitigators given at the time of right after
ionizing radiation exposure include antioxidants, growth factors and methods using
stem cells or progenitor cells that trigger regeneration, proliferation and survival of
healthy normal tissue.
Numerous chemotherapeutic anti-cancer drugs have been used to sensitize cells to ra-
diation including 5-fluorouracil, actinomycin D, cisplatin, gemcitabine, fludarabine,
paclitaxel, doxorubicin, hydroxyurea, mitomycin C, topotecan, or vinorelbine. The
radiosensitization mechanism differs between the chemotherapeutic agents.
Cisplatin, carboplatin, oxaliplatin and other platinum-containing chemotherapeu-
tics show the ability to crosslink with the purine bases on the DNA, suppressing
the DNA repair mechanisms, causing DNA damage, and subsequently leading to
apoptotic cancer cells death [67]. The radiosensitizing properties of topotecan can
be explained by the inhibition of DNA repair mechanisms namely inhibition of the
topoisomerase [68]. The proposed mechanisms of doxorubicin action are twofold and
include the intercalation to DNA followed by disruption of DNA repair and the gen-
eration of reactive oxygen species resulting in DNA, proteins and cellular membrane
damage [69]. Mitomycin C is more effective in sensitizing hypoxic cells [70]. Hydrox-
yurea leads to the inhibition of DNA synthesis and subsequent cell death in S-phase
of the cell cycle. Additionally, it prevents entry to the G1-phase synchronizing the
survival fraction of cells [71], whereas paclitaxel block cells in the G2/M-phase dis-
abling normal mitosis [72].
In HNSCC the EGFR is one of the key deregulated signaling pathways. Overexpres-
sion of EGFR in HNSCC is a strong and unfavorable prognostic factor [26, 73, 74].
The importance of the EGFR and its downstream PI3K/Akt/mTOR, NFκB and
MAPK survival pathways led to the development of small-molecule inhibitors and
blocking antibodies. Cetuximab to date was the most commonly used EGFR-specific
antibody, which substantially increased local-regional control in the first phases of
radiochemotherapy treatments [75, 76]. However, recent studies have identified sig-
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naling pathways activated by mutated KRAS, BRAF and NRAS genes that bypas
EGFR and mediate cetuximab radioresistance. Therefore, the use of cetuximab is
currently limited to patients who do not harbor KRAS mutations [77]. Accordingly,
inhibition of EGFR remains a challenge as complex networks are involved in the
EGFR signal propagation [78, 79]. The presence of strong feedback loops frequently
lower the effect of radiation therapy and often only specific combinations of inhibitors
are effective [80–86]. Therefore, one of the major challenges in targeted cancer ther-
apy is the prediction of effective combinatorial treatments [87]. Molecular systems
biology and mathematical modeling of signaling networks can facilitate understand-
ing of the role and functions of these networks and help finding the most suitable
treatment.
Implications of microarrays in clinical oncology
Analysis of genomic and transcriptomic data has contributed to a large number of
biological and clinical research studies. Microarray technology has been effectively
used for genome-wide expression profiling of various development processes, treat-
ments and diseases. Since its development in the middle of the 1990s, microarray
technology has been extensively used to understand and improve the knowledge of
complex experimental, scientific and medical problems. Traditional research has
mainly focused on functions of single genes involved in the development of a disease.
However, results based on investigations of individual genes can be misleading due
to the fact that single-gene inquiry ignores the high complexity of the gene regula-
tory network in which the gene of interest might be involved. One great advantage
of microarray technology is that it enables the investigation of the entire genome
simultaneously in a single experiment. This allows a better comprehension of the
gene regulations and signaling networks that might be concealed in single-gene based
studies [88].
Analysis of expression patterns across hundreds of clinical samples has been shown
to facilitate disease diagnosis, risk stratification and determination of therapeutic
regimens for specific groups of patients [89]. Carcinogenesis and cancer progression
are certainly one of the predominant focuses of microarray-based studies. Microar-
rays have been widely used to analyze different types of tumor, including breast,
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lung, leukemia, ovary, prostate, colorectal, head and neck, lymphoma and melanoma
[90–105]. Owing to the fact that gene expression plays a crucial role in determining
the clinical behavior of tumors, identification of expression patterns and underlying
mechanisms are the key aspects, essential for tumor therapy improvements. Microar-
ray technology offers the opportunity to extensively investigate tissue and genotype
specific transcriptional changes. Thus, it became a tool that enables prediction of
clinical outcome and helps to explore deregulated molecular mechanisms of complex
diseases.
Microarray technology
Microarray is a technology in which thousands of short, synthetic, single-stranded
DNA sequences are spotted on a solid surface, usually on a glass slide. Each printed
spot is typically not larger than 200 microns in diameter and contains multiple iden-
tical and unique DNA oligonucleotides. Single microarray comprises of thousands
of different spotted samples (known as probes) representing single genes. During
the hybridization step, fluorescently labeled RNA or DNA samples of interest are
matched with annotated microarray probes based on nucleic acid sequence homol-
ogy. The amount of RNA or DNA bound to each spot indicates the expression levels
[106].
Two types of microarrays were used in the presented thesis, the two-channel com-
parative genomic hybridization and the single-channel gene expression microarrays.
The schematic workflow for the sample preparation and microarray processing for
those two microarray types is presented and described in Figure 1.
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Figure 1. Schematic workflow for sample preparation and microarray processing.
The upper panel (A) illustrates the two-channel array-based comparative genomic hybridization
(aCGH) technology and the lower panel (B) shows the single-channel gene expression (GE) mi-
croarray technology. For the aCGH the reference and the experimental DNA samples are labeled
with two different fluorescent dyes (Cy3 and Cy5) and pooled before being hybridized on the same
array. For the GE microarrays each sample is labeled with the same fluorescent dye (Cy3), but
independently hybridized on different arrays.
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Studying and modeling dynamics in biological processes
Gene expression can be studied from a static or temporal point of view. Static ex-
periments allow measuring transcriptional responses at one pre-defined time point
capturing only a snapshot of the gene expression. However, most of the biological
processes are dynamic and the expression of a gene can vary greatly with time [107].
Therefore, hypotheses build on single-time-point experiments may be misleading and
not realistic for understanding complex biological processes. Different sets of genes
have different kinetics of response to different stimuli. Consequently, the complete
response can be only modeled when the process is followed at numerous time points.
In general, time-course studies can be classified into three experimental types, de-
pending on the design of the study and study interests [108]. The first type has
one experimental condition and a corresponding development phase. Accordingly,
all time points are examined in contrast to the first time point, which is consid-
ered as a control. However, this experimental study type does not provide a proper
control over the entire time-course which is a major disadvantage of this approach.
The second experimental type categorizes studies with a factorial time-course design
that consider multiple treatment conditions simultaneously. This design includes at
least two treatment conditions that for a given time point have different temporal
expression patterns. Here, the time-course data from one treatment group is com-
pared to the time-course data of the other treatment group(s). Thus, this approach
ensures better control of the experiment on the grounds that compared samples are
probed over time in parallel. Additionally, the comparison of the gene expression
patterns between the treatment groups can be performed independently at any time
point. However, in light of the fact that this approach requires more samples, the
performance is considerably more expensive. The third type of time-course studies
includes periodic and cyclic experiments (e.g. cell cycle), where the main research
interests are focused on repeated expression patterns.
Analyses of the time-course experiments in principle follow the same workflow as
static experiments (Figure 2). However, comparing to the static data, the analysis
of time-course data introduces a number of new challenges. First, the computational
complexity of data analysis increases with the increase in the number of feature
points. Second, hidden correlation caused by co-expression of genes makes the data
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Figure 2. Overview on different modalities of transcriptomic data analysis.
Time-course experiments follow the same workflow as static experiments and can be divided
into three parts: 1) data preprocessing by data quality assessment, filtering, normalization and
batch correction; 2) differential gene expression analyses; and 3) downstream analyses including
classification and clustering methods, functional enrichment analyses, gene association networks
reconstructions and validation of candidate genes.
linearly dependent [109]. Finally, one has to be aware of additional correlations exist-
ing between neighboring time points explicitly disclosed and illustrated in published
gene expression profiles [110].
Despite all the existing difficulties of temporal gene expression data analysis, such
data can be used to systematically characterize functions of particular genes and to
infer their interactions with other genes. This knowledge holds the promise of ex-
plaining the relevant mechanisms of different biological processes and may facilitate
the molecular target identification of novel pharmaceutical drugs [111]. Therefore,
the analyses of the cellular radiation response presented in both of my publications
were based on the second experimental type time-course study design to be able to
explore the gene expression dynamics.
Gene association networks
Multidimensional datasets from gene expression microarray experiments are nowa-
days extensively used to uncover unknown relationships between genes. Elucidating
networks, which delineate signaling pathways and regulatory mechanisms coordi-
nating multiple molecular processes is one of the most important aims of systems
biology.
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The process of gene association network reconstruction known also as "reverse engi-
neering" aims to model the complex cellular regulatory interactions and propose a re-
alistic illustration of gene regulation. Several different methods have been suggested
and used to reconstruct gene association networks (GANs) including graph theory,
Boolean and Bayesian networks, ordinary differential equations, machine learning
or correlation approaches [112, 113]. Moreover, the revealed network topologies pro-
vide the information how the organization of genes in the network influences their
functions and dynamic responses [114].
In both publications of this thesis the GAN reconstructions of temporally differ-
entially expressed genes following radiation were performed using the regularized
dynamic partial correlation method [115]. The topological properties of obtained
networks were addressed with three different centrality measures (degree, closeness
and shortest path betweenness) in order to identify nodes with strategic positions
for controlling the network.
The degree centrality is the measure of gene communication activity and defines the
number of other genes (nodes) that are directly connected to the gene of interest.
Closeness centrality is described as the inverse of the sum of distances of a single
gene to other genes. A gene in the closest position to all others can most efficiently
attain and pass signals in the network. Betweenness centrality of a node is defined as
the ratio between the number of shortest paths passing through the given gene and
the number of shortest paths between any pair of genes. This shows the potential
of a gene for controlling the signal transduction within the network [116–118].
Publication I of this thesis provided the methodological basis to explore the radiation
response in normal and HNSCC cells (publication II) by focussing on the following
aims.
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Aims and objectives
The overall aim of my thesis was to develop a statistical approach that allows study-
ing the molecular mechanisms of temporal gene expression responses from
time-course global transcriptomic data. To reach this aim a number of specific aims
had to be addressed. The first one comprised the design and implementation of an
algorithm based on natural cubic spline regression models for the detection of tempo-
rally differentially expressed genes between different treatment groups. Further, the
identified genes were used as prior selection for subsequent gene association network
reconstruction by employing regularized dynamic partial correlation method. With
this method, I aimed to determine dependencies between the differentially expressed
genes based on their expression behavior.
The major challenge in the analysis of high-dimensional expression data sets is the
assessment of which single genes or entire cellular processes are the most relevant
ones in the case study. Therefore, subsequent topological analysis of the recon-
structed networks by a hybrid centrality measure aimed to define a subset of nodes
that are likely to play an important role in controlling the signal transduction within
the networks. The identified so-called hub genes were then subjected to pathway en-
richment analysis, which allowed determining the possibly relevant cellular mecha-
nisms involved in the current study. The objective of the presented approach was the
reduction of the number of candidate biological processes being used as hypotheses
for further validation in follow-up experiments.
Another important aim of my thesis was the application of the proposed algorithm
on two data sets of normal and tumor cell culture models with different cellular
radiation sensitivity. With the obtained results I aimed to provide insights into the
mechanisms of acute radiation response of the hypersensitive non-tumor lymphoblas-
toid cells in comparison to the lymphoblastoid cells with normal radiation sensitivity.
Moreover, with the presented approach I attempted to indicate the molecular differ-
ences of radiation responses in the radioresistant HNSCC derived CAL-33 cell lines
with altered acquired radiation sensitivity.
The precise mechanisms behind the acute radiation response of normal cells and
tumor radioresistance are still largely unknown [25, 119, 120]. Therefore, within
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this thesis I aimed to find clinically relevant molecular targets that could serve as
modulators of radiation sensitivity in order to improve tumor radiotherapy outcome.
Summary
The major therapeutic aim of radiotherapy is the maximization of tumor tissue eradi-
cation whilst preserving the surrounding normal tissue. Thus, the underlying cellular
radiation response is the most important determinant of the radiotherapy success in
tumor treatment and the ability to modulate radiosensitivity is a prerequisite to
improve the therapy outcome. Despite numerous experimental and clinical studies
on radiation sensitivity in different cell types, the molecular mechanisms of acute
radiation response and tumor radioresistance still remain unclear. So far, the major
limitation of many previous studies was the consideration of single molecular levels
or the usage of only static data in order to unravel molecular mechanisms of radiation
response. However, biological processes are dynamic and therefore, the integration
of time-course data is essential.
In my thesis I have proposed and developed a statistical approach that allows study-
ing molecular mechanisms of temporal gene expression responses from a time-course
global transcriptomic data. The approach comprised three major steps: 1) the iden-
tification of differentially expressed genes from time-course expression data by em-
ploying natural cubic spline regression models (NCSRM); 2) the use of regularized
dynamic partial correlation to infer gene associations networks (GANs) from differ-
entially expressed genes; and 3) the topological identification and functional char-
acterization of the key nodes in the reconstructed networks. Subsequently, the pro-
posed approach was applied on a time-resolved transcriptome data set of
radiation-perturbed cell culture models of: 1) monoclonal lymphoblastoid cell lines
(LCLs) with normal and increased radiation sensitivity and 2) HNSCC-derived
CAL-33 cell lines with different acquired radiation resistance.
Two lymphoblastoid cell lines with increased and normal radiation sensitivity that
served as cell culture models of normal cells, were irradiated with γ-irradiation at two
different doses (1 Gy and 10 Gy). The changes in mRNA expression levels were stud-
ied over time within 24 hours following radiation. Gene association networks were
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determined and the obtained results underlined the impact of senescence-associated
pathways in acute radiation response of normal cells.
Several HNSCC-derived CAL-33 cell lines, with altered acquired radiation sensitivity
after fractionated radiation treatment, were used as models of radioresistant tumor
cells. The cell lines showing different radiation phenotypes were investigated at the
genomic and transcriptomic levels in order to identify mechanisms responsible for
distinct radiation responses. Furthermore, the cells were irradiated with X-rays at
a dose of 8 Gy (dose showing the most pronounced phenotypical changes) and the
mRNA gene expressions were investigated within 4 days following radiation in a
time-course study design. Following network reconstruction a key finding was the
important role of senescence-associated secretory phenotype (SASP) and GPCR lig-
and binding pathways for the resistant phenotype response.
The results of the studies obtained using the novel approach generate hypotheses
about genes and signaling networks that may play a crucial role in the investigated
processes. Thus, the proposed method is able to contribute to a better understand-
ing of the underlying molecular mechanisms and targets that are involved in the
radiation response of human cells and by this providing a starting point for an im-
provement of radiotherapy outcome.
Zusammenfassung
Strahlentherapie verfolgt als wichtigstes therapeutisches Ziel die maximale Elim-
inierung von Tumorgewebe bei gleichzeitiger Schonung des umgebenden Normal-
gewebes. Aus diesem Grund ist die zugrunde liegende zelluläre Strahlenantwort der
bestimmende Faktor für den Erfolg der Strahlentherapie und demnach die Möglichkeit
zur Modulation der Strahlenempfindlichkeit die Voraussetzung für eine Verbesserung
des Therapieverlaufs. Trotz zahlreicher experimenteller und klinischer Studien zur
Strahlenempfindlichkeit in verschiedenen Zelltypen sind die molekularen Mechanis-
men der akuten Strahlenantwort und Strahlenresistenz von Tumoren bislang nur
unzureichend verstanden. Viele bisherige Studien waren dadurch limitiert, dass nur
einzelne molekularen Ebenen betrachtet wurden oder ausschließlich statische Daten
verwendet wurden. Alle biologischen Prozesse sind allerdings dynamisch und somit
ist für die vollständige Charakterisierung der molekularen Mechanismen der
Strahlenantwort die Integration von zeitabhängigen Daten unabdingbar.
Im Rahmen dieser Dissertation habe ich einen statistischen Forschungsansatz en-
twickelt, der - ausgehend von zeitabhängigen globalen Transkriptionsdaten - die
zeitaufgelöste Analyse von Genexpressionsdaten ermöglicht. Dieser Forschungsansatz
berücksichtigt drei wesentliche Schritte: 1) die Identifizierung von differentiell
exprimierten Genen ausgehend von zeitaufgelösten Genexpressionsdaten durch
Anwendung sogenannter Regressionsmodelle mit natürlichen kubischen
Spline-Basisfunktionen; 2) die Anwendung von regularisierter dynamischer partieller
Korrelation für die Ableitung von Gen-Assoziations-Netzwerken ausgehend von dif-
ferentiell exprimierten Genen und 3) die topologische Identifizierung und funktionelle
Charakterisierung von zentralen Knoten in den rekonstruierten Netzwerken. Die
entwickelte Methode wurde auf zeitaufgelöste Transkriptionsdaten strahlenbehan-
delter Zellkulturmodellen angewandt: 1) von monoklonalen lymphoblastoiden Zel-
llinien (LCLs) mit jeweils normaler und erhöhter Strahlenempfindlichkeit und 2) von
HNSCC CAL-33 Zelllinien mit einer unterschiedlichen erworbenen Strahlenresistenz.
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Einerseits wurden zwei lymphoblastoide Zelllinien mit normaler und erhöhter
Strahlenempfindlichkeit, welche als Zelllinien Modell für Normalzellen verwendet
wurden, mit zwei verschiedenen Dosen (1 Gy und 10 Gy γ-Strahlung) bestrahlt.
Die Änderungen in der Genexpression wurden über einen Zeitraum von 24 Stunden
nach Bestrahlung untersucht. Die Ergebnisse der Netzwerkrekonstruktion zeigten
die Bedeutung von Seneszenz-assoziierten Signalwegen bei der akuten Strahlenant-
wort von Normalzellen.
Andererseits wurden HNSCC CAL-33 Zelllinien mit unterschiedlicher erworbener
Strahlenempfindlichkeit als Modelle für strahlenresistente Tumorzellen verwendet.
Die Zelllinien, welche unterschiedliche Phänotypen nach Bestrahlung zeigten, wur-
den auf genomischer und transkiptomischer Ebene untersucht, um Mechanismen der
Strahlenantwort zu identifizieren. Dabei wurden die Zellen mit 8 Gy Röntgen-
strahlung (die Dosis mit den stärksten phänotypischen Unterschieden) bestrahlt und
die Genexpressionen zeitabhängig während der folgenden vier Tage nach Bestrahlung
bestimmt. Nach Netzwerkrekonstruktion trat die Bedeutung des Seneszenz
-assoziierten sekretorischen Phänotyps (SASP) und des GPCR ligand binding Sig-
nalwegs für die Ausprägung einer resistenten Strahlenantwort zu Tage.
Die Ergebnisse der durchgeführten Studien unter Verwendung des neuartigen statis-
tischen Ansatzes haben zu Hypothesen über Gene und Signalnetzwerke geführt, die
eine entscheidende Rolle bei der Strahlenantwort von Tumor- und Normalzellen spie-
len könnten. Somit kann die neu entwickelte statistische Methode dazu beitragen,
die der Strahlenantwort von menschlichen Zellen zugrunde liegenden molekularen
Mechanismen aufzuklären, die ihrerseits Ansatzpunkte für eine Verbesserung des
klinischen Verlaufs nach Strahlentherapie darstellen.
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Abstract
Gene expression time-course experiments allow to study the dynamics of transcriptomic
changes in cells exposed to different stimuli. However, most approaches for the reconstruc-
tion of gene association networks (GANs) do not propose prior-selection approaches tai-
lored to time-course transcriptome data. Here, we present a workflow for the identification of
GANs from time-course data using prior selection of genes differentially expressed over
time identified by natural cubic spline regression modeling (NCSRM). The workflow com-
prises three major steps: 1) the identification of differentially expressed genes from time-
course expression data by employing NCSRM, 2) the use of regularized dynamic partial
correlation as implemented in GeneNet to infer GANs from differentially expressed genes
and 3) the identification and functional characterization of the key nodes in the recon-
structed networks. The approach was applied on a time-resolved transcriptome data set of
radiation-perturbed cell culture models of non-tumor cells with normal and increased radia-
tion sensitivity. NCSRM detected significantly more genes than another commonly used
method for time-course transcriptome analysis (BETR). While most genes detected with
BETR were also detected with NCSRM the false-detection rate of NCSRM was low (3%).
The GANs reconstructed from genes detected with NCSRM showed a better overlap with
the interactome network Reactome compared to GANs derived from BETR detected genes.
After exposure to 1 Gy the normal sensitive cells showed only sparse response compared
to cells with increased sensitivity, which exhibited a strong response mainly of genes related
to the senescence pathway. After exposure to 10 Gy the response of the normal sensitive
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cells was mainly associated with senescence and that of cells with increased sensitivity
with apoptosis. We discuss these results in a clinical context and underline the impact of
senescence-associated pathways in acute radiation response of normal cells. The workflow
of this novel approach is implemented in the open-source Bioconductor R-package
splineTimeR.
Introduction
In general terms, the expression of genes can be studied from a static or temporal point of view.
Static microarray experiments allow measuring gene expression responses only at one single
time point. Therefore, data obtained from those experiments can be considered as more or less
randomly taken snapshots of the molecular phenotype of a cell. However, biological processes
are dynamic and thus, the expression of a gene is a function of time [1]. To be able to under-
stand and model the dynamic behavior and association of genes, it is important to study gene
expression patterns over time.
However, compared to static microarray data, the analysis of time-course data introduces a
number of new challenges. First, the experimental costs for the generation of data as well as the
computational cost increases with the increase in the number of introduced time points. Sec-
ond, hidden correlation caused by co-expression of genes makes the data linearly dependent
[2]. Finally, one has to be aware of additional correlations existing between neighboring time
points clearly revealed in published gene expression profiles [3].
Several different algorithms have been suggested to analyze gene time-course microarray
data with regard to differential expression in two or more biological groups (e.g. exposed to
radiation vs. non-exposed) [4–7]. Nevertheless solitary identification of differentially expressed
genes does not help to determine the molecular mechanisms in the investigated biological
groups. Therefore, it is not only important to know differentially expressed genes per se, but
also how those genes interact and regulate each other in order to determine specifically deregu-
lated molecular networks.
Currently, many different algorithms including cluster analysis [8–13] and supervised clas-
sification [14–16] are used to identify relationships between genes. However, both of these
methods suffer from serious limitations. First, the timing information of the measurements is
not incorporated and, therefore, the intrinsic temporal structure of the time-course data is
neglected. Second, the available standard clustering and classification methods are not designed
to measure statistical significance of the results based on a statistical hypothesis test. By nature
of these methods, clusters or classes of genes with similar expression patterns will always be
identified but they do not provide a measure of how reliable this information is. For this reason,
we preferred usage of a dynamic network modeling approach that allows delineation of rela-
tionships between genes along with providing statistical significance for these relationships.
The aim of the present study was to identify and compare signaling pathways involved in the
radiation responses of normal cells differing in their radiation sensitivity that could be used to mod-
ulate cell sensitivity to ionizing radiation. For this, we propose an approach that combines the detec-
tion of genes differentially expressed over time based on statistics determined by natural cubic spline
regression (NCSRM) [17] followed by dynamic gene association network (GAN) reconstruction
based on a regularized dynamic partial correlation as implemented in the GeneNet R-package [18].
Most exploratory gene expression studies focus only on the identification of differentially
expressed genes by treating them as independent events and do not seek to study the interplay
of identified genes. This makes it difficult to tell which genes are part of the interaction network
Spline Regression and Network Reconstruction for Time-Course Expression Data
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causal of the studied phenotype and which are the most “important” with regard to the context
of the investigation. The herein present approach combines the identification of differentially
expressed genes and reconstruction of possible associations between them. Further analysis of
identified GANs then allows hypothesizing which genes may play a crucial role in the investi-
gated processes. This should markedly increase the likelihood to find meaningful results from
an initial observation and help to understand the underlying molecular mechanisms. We
applied our workflow on time-course transcriptome data of two normal and well-characterized
lymphoblastoid cell lines with normal (20037–200) and increased radiation sensitivity (4060–
200), in order to identify molecular mechanisms and potential key players responsible for dif-
ferent radiation responses [19, 20]. Our exploratory approach provides novel and informative
insights in the biology of radiation sensitivity of non-tumor cells after exposure to ionizing
radiation with regard to the identified signaling pathways and their key drivers. Moreover, we
could demonstrate that spline regression in differential gene expression analysis for the pur-
pose of prior selection in gene-association network reconstruction outperforms another com-
monly used existing approach for time-course gene expression analysis.
Results
The schematic workflow of the presented novel approach for time-course gene expression data
analysis is presented in Fig 1.
Identification of ionizing radiation-responsive genes using NCSRM
method
A fraction of the probes was removed due to low expression levels, with not detectable signal
intensities as described in [21]. Table 1 shows the number of probes remained after quality filter-
ing from the total number of 25220 unique probes representing HGNC annotated genes. Differ-
ential analysis was performed relative to the corresponding sham irradiated cells as a reference.
In general, more genes were detected as differentially expressed in the cells with increased radia-
tion sensitivity compared to cells with normal radiation sensitivity after each dose of gamma irra-
diation (Table 1). The most prominent difference was observed when comparing the responses
after 1 Gy irradiation. In the cells with increased radiation sensitivity 2335 genes showed differen-
tial expression compared to only seven genes in cells with normal radiation sensitivity. We
observed the same trend after irradiation with 10 Gy where the cells with increased sensitivity
showed 6019 and the normal sensitive cells 3892 differentially expressed genes.
Pathway enrichment analysis of NCSRM identified genes
Pathway enrichment analysis was performed on differentially expressed genes to identify over-
represented biological pathways. The analysis on genes identified with NCSRM revealed 634
and 964 significantly enriched pathways for the cells with increased radiation sensitivity after 1
Gy and 10 Gy irradiation dose, respectively and 758 pathways for the normal sensitive cell line
after 10 Gy irradiation. For the seven differentially expressed genes (i.e. FDXR, BBC3, VWCE,
PHLDA3, SCARF2, HIST1H4C, PCNA) of the cell line with normal radiation sensitivity after
1 Gy dose of irradiation we did not find any significantly enriched pathways. A summary of the
pathway enrichment results can be found in S2 Table.
Gene association network reconstruction
None of the edge probabilities calculated for the seven differentially expressed genes in the cell
line with normal radiation sensitivity after 1 Gy irradiation exceeded the considered
Spline Regression and Network Reconstruction for Time-Course Expression Data
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significance threshold and hence no network was obtained. For the remaining conditions we
were able to obtain association networks as presented in Table 2. Obtained networks are pro-
vided as igraph R-objects in the supplementary data (S1 File). The graph densities for all result-
ing networks were in the same range as the density of the Reactome interaction network
(Table 2).
Identification and functional characterization of the most important
genes in the reconstructed association networks
The combined topological centrality measure was used to characterize the biological impor-
tance of nodes (genes) in the reconstructed association networks. The 5% of the highest ranked
genes listed in supplementary S3 Table were mapped to Reactome pathways in order to further
evaluate their biological roles. The top 10 most relevant pathways according to the FDR values
are shown in Table 3. For the cell line with increased radiation sensitivity after irradiation with
1 Gy and for the normal sensitive cell line after 10 Gy the induction of pathways associated
with senescence response was detected. For the cell line with increased radiation sensitivity
after 10 Gy of irradiation we mostly observed pathways associated with apoptosis. All pathways
are listed in supplementary S4 Table.
False detected differentially expressed genes between technical replicates
In order to assess the false positive rate, the spline regression based differential analyses between
technical replicates of each treatment conditions and cell lines were performed. Here, we can
state that the null-hypothesis of no differential expression is true for all genes. Then the q-level
of 0.05 for Benjamini-Hochberg method controls also the FWER at alpha-level equal to 0.05
(type I error) [22]. For all compared technical replicates not more than 3% rejections of null
hypothesis were detected, which is in good accordance to the expected or nominal type I error.
Evaluation of spline regression model in comparison to BETRmethod
Table 1 compares the numbers of differentially expressed genes obtained from both methods
applied on the same gene expression data set and FDR thresholds. For almost all treatment
conditions the BETRmethod detected less differentially expressed genes in comparison to
Fig 1. Schematic workflow of the analysis of gene expression time-course data. Samples were collected 0.25, 0.5, 1, 2, 4, 8 and 24 hours after
sham or actual irradiation. Transcriptional profiling was performed using Agilent gene expression microarrays and comprises three major steps: the
identification of differentially expressed genes from time-course expression data by employing a natural cubic spline regression model; the use of
regularized dynamic partial correlation method to infer gene associations networks from differentially expressed genes and the topological identification
and functional characterization of the key nodes in the reconstructed networks.
doi:10.1371/journal.pone.0160791.g001
Table 1. Number of detected and differentially expressed genes for each dose and cell lines for NCSRM and BETRmethods.
cell line and applied radiation dose increased sensitivity (1
Gy vs 0 Gy)
Normal sensitivity (1
Gy vs 0 Gy)
increased sensitivity (10
Gy vs 0 Gy)
Normal sensitivity (10
Gy vs 0 Gy)
total number of detected probes after
preprocessing
10388 11311 10330 11446
differentially expressed genes detected with
NCSRM
2335 7 6019 3892
differentially expressed genes detected with
BETR
923 12 3889 1256
intersection of differentially expressed genes
resulting from both methods
855 4 3875 1233
doi:10.1371/journal.pone.0160791.t001
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NCSRM. Only for the normal cell line after irradiation with 1 Gy BETR identified 12 genes
whereas NCSRM identified only 7 genes. As a consequence of the lower numbers of detected dif-
ferentially expressed genes with BETR, the obtained networks are smaller than those obtained
after spline regression. The detailed comparison results including numbers of detected differen-
tially expressed genes and the sizes of reconstructed association networks are presented in the
Table 2. The lists of differentially expressed genes obtained with the two methods are shown in
supplementary S1 Table. The top 10 pathways to which the 5% of the most important genes in
the reconstructed association networks where mapped to are shown in Table 3. With NCSRM
we were not only able to detect almost all genes that were detected also by BETR (Table 1), but
also an additional set of genes resulting in almost twice the number of genes compared to BETR.
Nevertheless, the top 5% hub genes of the networks derived from the differentially expressed
genes defined by BETR were associated with similar biological processes as those from the spline
differential expression analysis derived networks. The numbers and names of overlapping hub
genes in the GANs are presented in Table 4 and in supplementary S3 Table, respectively.
Evaluation of reconstructed networks
The evaluation of the two networks derived after 1 Gy irradiation of the cell line with increased
sensitivity showed that the network reconstructed with the differentially expressed genes deter-
mined using BETR did not contain significantly more common edges than random networks
(p = 0.529), whereas the network reconstructed with the differentially expressed genes deter-
mined by NCSRM did (p = 0.048). The networks derived after 10 Gy irradiation of the cell line
with increased sensitivity and 10 Gy irradiation of the normal sensitive cell line contained sig-
nificantly more edges that were common with the Reactome network compared to random
networks for both methods.
Discussion
The success of tumor radiation therapy predominantly depends on the total applied radiation
dose, but also on the tolerance of the tumor surrounding normal tissues to radiation. Toxicity
Table 2. Number of genes subjected to GAN reconstruction and properties of resulted GANs.
method NCSRM BETR
cell line and
applied radiation
dose
Increased
sensitivity (1
Gy)
normal
sensitivity (1
Gy)
Increased
sensitivity (10
Gy)
normal
sensitivity (10
Gy)
Increased
sensitivity (1
Gy)
normal
sensitivity (1
Gy)
Increased
sensitivity (10
Gy)
normal
sensitivity (10
Gy)
number of genes
taken for network
reconstruction
2335 7 6019 3892 923 12 3889 1256
number of nodes
remained in the
network
1140 - 3483 2735 336 - 2299 773
number of edges in
the network
12198 - 114629 84695 3268 - 126378 16862
network density 0.00939 - 0.00945 0.01133 0.02903 - 0.02392 0.02826
density of the
Reactome
interaction network
0.00536
Gene association network reconstructions were performed using the GeneNet method [18]. Association between two genes was considered as signiﬁcant if
posterior edge probability was equal or greater than 0.95. Densities of the reconstructed networks were compared with the density of the Reactome
interaction network in order to assess their complexity.
doi:10.1371/journal.pone.0160791.t002
Spline Regression and Network Reconstruction for Time-Course Expression Data
PLOS ONE | DOI:10.1371/journal.pone.0160791 August 9, 2016 6 / 19
Publication I 30
towards radiation, which greatly varies on an individual level due to inherited susceptibility, is
one of the most important limiting factors for dose escalation in radiooncology treatment [23,
24]. To account for radiation sensitivity of normal tissue in personalized treatment approaches
the underlying molecular mechanisms need to be thoroughly understood in order to identify
Table 3. Comparison of NCSRM and BETRmethodswith respect to the top 10 pathways after mapping of 5% highest ranked genes from the recon-
structed gene association networks.
with NCSRMmethod with BETRmethod
increased sensitivity
(1 Gy)
increased sensitivity (10
Gy)
normal sensitivity (10
Gy)
increased sensitivity (1
Gy)
increased sensitivity (10
Gy)
normal sensitivity
(10 Gy)
Signal Transduction Signal Transduction Generic Transcription
Pathway
DNA Damage/Telomere
Stress Induced
Senescencea
Activation of BH3-only
proteinsb
DNA Damage/
Telomere Stress
Induced
Senescencea
Cellular Senescencea Activation of BH3-only
proteinsb
DNA Damage/
Telomere Stress
Induced Senescencea
Senescence-Associated
Secretory Phenotype
(SASP)a
Activation of PUMA and
translocation to
mitochondriab
Generic
Transcription
Pathway
DNA Damage/
Telomere Stress
Induced Senescencea
Activation of PUMA and
translocation to
mitochondriab
Immune System Signal Transduction Cytokine Signaling in
Immune system
Cellular
Senescencea
Formation of
Senescence-
Associated
Heterochromatin Foci
(SAHF)a
Fatty acid, triacylglycerol,
and ketone body
metabolism
Gene Expression Activated PKN1
stimulates transcription
of AR (androgen
receptor) regulated
genes KLK2 and KLK3
Immune System Gene Expression
Cellular responses to
stress
Metabolism Inositol phosphate
metabolism
Cell Cycle Checkpoints Intrinsic Pathway for
Apoptosisb
Meiotic
recombination
RAF-independent
MAPK1/3 activation
Metabolism of proteins IRF3-mediated
induction of type I IFN
Cellular Senescencea Signal Transduction Signal Transduction
Signaling by ERBB4 PPARA activates gene
expression
Cellular Senescencea DNAmethylation Gene Expression Cell Cycle
DAP12 interactions Regulation of lipid
metabolism by
Peroxisome proliferator-
activated receptor alpha
(PPARalpha)
Formation of
Senescence-
Associated
Heterochromatin Foci
(SAHF)a
Packaging Of Telomere
Ends
BH3-only proteins
associate with and
inactivate anti-apoptotic
BCL-2 membersb
Transcriptional
activation of cell
cycle inhibitor p21
PRC2 methylates
histones and DNA
Activation of gene
expression by SREBF
(SREBP)
STING mediated
induction of host
immune responses
RNA Polymerase I
Promoter Opening
Activation of the mRNA
upon binding of the cap-
binding complex and
eIFs, and subsequent
binding to 43S
Transcriptional
activation of p53
responsive genes
Apoptotic execution
phaseb
BH3-only proteins
associate with and
inactivate anti-apoptotic
BCL-2 membersb
Metabolism SIRT1 negatively
regulates rRNA
Expression
Endosomal/Vacuolar
pathway
Senescence-
Associated
Secretory
Phenotype (SASP)a
aPathways associated with senescence responses.
bPathways associated with apoptotic processes.
doi:10.1371/journal.pone.0160791.t003
Table 4. Comparison of hub genes in networks resulting from different methods.
cell line and applied radiation dose increased sensitivity (1 Gy) increased sensitivity (10 Gy) Normal sensitivity (10 Gy)
5% hub genes in the NCSRM resulting network in numbers 57 174 137
5% hub genes in the BETR resulting network in numbers 17 115 39
number of common hub genes resulting from both methods 9 111 31
doi:10.1371/journal.pone.0160791.t004
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molecular targets for the modulation of radiation sensitivity and molecular markers for the
stratification of patients with different intrinsic radiation sensitivity. In the present study we
identified significantly differentially expressed genes over time between the radiation-treated
group and the control group to be used as prior genes for GAN reconstruction. Two doses of
gamma irradiation were used to characterize the differences in radiation response of the two
lymphoblastoid cell lines with known differences in radiation sensitivity. The dose of 10 Gy
was selected following the fact that the same dose has been applied in a previous research proj-
ect examining the radiation sensitivity of the same lymphoblastoid cell lines analyzed in the
study at hand [20]. The dose of 1 Gy reflects the dose that is delivered as part of the so called
“low-dose bath” to the tumor-surrounding tissue during the radiotherapy of the tumors [25].
Here, we conducted time-resolved transcriptome analysis of radiation-perturbed cell culture
models of non-tumor cells with normal and with increased radiation sensitivity in order to
work out the molecular phenotype of radiation sensitivity in normal cells. Moreover, we pres-
ent an innovative approach for the identification of GANs from time-course perturbation tran-
scriptome data. The approach comprises three major steps: 1) the identification of
differentially expressed genes from time-course gene expression data by employing a natural
cubic spline regression model (NCSRM); 2) the use of a regularized dynamic partial correlation
method to infer gene associations network from differentially expressed genes; 3) the identifi-
cation and functional characterization of the key nodes (hubs) in the reconstructed gene
dependency network (Fig 1).
Our proposed method for the detection of differentially expressed genes over time is based
on NCSRM with a small number of basis functions. A relatively low number of basis functions
generally results in a good fit of data and, at the same time, reduces the complexity of the fitted
models. Treating time in the model as a continuous variable, a non-linear behavior of gene
expressions was approximated by spline curves fitted to the experimental time-course data.
Considering temporal changes in gene expression as continuous curves and not as single time
points greatly decreases the dimensionality of the data and thereby decreases computational
cost. In addition, the proposed NCRSM does not require identical sampling time points for the
compared treatment conditions. Furthermore, no biological replicates are needed. Therefore,
the method is applicable to data generated according to a tailored time-course differential
expression study design and to data that were not specifically generated for time-course differ-
ential expression analysis, e.g. existing/previously generated data from clinical samples. Thus,
the adaption of the method to differential expression analysis comprises the potential to reana-
lyze existing data, address new questions in silico and thereby potentially add new or additional
value to existing data. Incomplete time-course data, e.g. due to the exclusion of samples for
technical reasons, that often create major problems for the estimation of the model, are also
suitable for fitting the spline regression model as long as enough data points remain in the data
set. This is especially valuable when data on certain time points, derived from a very limited
sample source, have been excluded from a time-course data set and cannot be repeatedly
generated.
Since gene expression is not only dynamic in the treatment group but also in the control
group, the inclusion of the time-course control data greatly improves the ability to detect truly
differentially expressed genes, as the gene expression values are not referred to a single time
point with static gene expression levels only. Comparing a treatment group to time point zero
does not provide a proper control over the entire time-course, although it is widely practiced
[26–28]. The proposed workflow is implemented in an open-source R-package splineTimeR
and is available through Bioconductor (https://www.bioconductor.org).
Amongst a panel, the two lymphoblastoid cell lines that were different with regard to radia-
tion sensitivity after irradiation with 10 Gy [20], also responded differently with regard to the
Spline Regression and Network Reconstruction for Time-Course Expression Data
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quantity of differentially expressed genes. Interestingly, cells with normal radiation sensitivity
barely responded to 1 Gy irradiation at the transcriptome level. Only seven genes (FDXR,
BBC3, VWCE, PHLDA3, SCARF2, HIST1H4C, PCNA) were identified as differentially
expressed, whereas for the cell line with increased sensitivity 2335 differentially expressed
genes were detected after exposure to the same dose. A similar behavior was observed for those
two cell lines after irradiation with 10 Gy. We detected 6019 and 3892 genes as differentially
expressed in the sensitive and normal cell lines, respectively (Table 2). Those results are in a
good agreement with the previous proteomic study where more differentially expressed pro-
teins were detected for the same sensitive cell line compare to the cell line with normal radia-
tion sensitivity 24 hours after irradiation with 10 Gy [29]. Thus, for both applied doses, the
radiation sensitive cells exhibited much more pronounced transcriptional response compared
to the cells with normal radiation sensitivity and thereby underlines the expected radiation
response of those two cell lines.
Concerning qualitative differences in the transcriptomic response of normal sensitive cells
and cells with increased sensitivity after treatment with 1 Gy and 10 Gy pathway enrichment
analysis was performed. Differentially expressed genes identified for all considered treatment
conditions except for the normal sensitive cells after exposure to 1 Gy radiation showed statisti-
cally significant enrichment of pathways. Most of which were in agreement with known radia-
tion responses such as DNA repair, cell cycle regulation, oxidative stress response or pathways
related to apoptosis (S2 Table) [30–32]. Therefore, the pathway enrichment analysis results
suggest plausibility of generated data and, more importantly, underline the meaningfulness of
our suggested approach based on cubic spline regression for differential gene expression analy-
sis of time-course data. However, differential expression analysis alone followed by pathway
enrichment analysis does not provide any mechanistic insights. For this reason we performed
GAN reconstruction using identified differentially expressed genes. Based on the assumption
that the expression levels of functionally related genes are highly correlated, partial correlation
was used for GAN reconstruction. In simple correlation, the strength of the linear relationship
between two genes is measured, without taking into account that those genes may be actually
influenced by other genes. Partial correlation eliminates the influence of other genes when one
particular relationship between pair of genes is considered. Network reconstruction was per-
formed separately for the cell line with increased radiation sensitivity after 1 Gy and 10 Gy and
for the cell line with normal radiation sensitivity after 10 Gy of radiation dose. Due to the
sparseness of the set of genes differentially expressed after irradiation of the normal-sensitive
cell line with 1 Gy, no GAN was obtained.
Subsequently, we identified the network hubs (i.e. most important genes) of the GANs by
combining three network centrality measures: degree, closeness and shortest path betweenness
[33]. Combining different centrality measures is a widely used approach to identify nodes that
are likely to control the network [34]. Also, this approach allows identification of nodes that
are connected to the central nodes at the same time which can be informative for the interpre-
tation of the whole GAN or single modules making up the network [33, 34].
Identification of key pathways associated with radiation sensitivity
In order to get functional insights into the reconstructed GANs the 5% top important nodes
were identified after a ranking with the combined centrality measure and mapped to the path-
ways from the interactome database Reactome [35]. The obtained results revealed different
pathways considered as the most important in cells with different radiation sensitivity after dif-
ferent doses of ionizing radiation. For the radiation sensitive cell line 4060–200 and 1 Gy irradi-
ation, we mainly detected pathways associated with senescence (Table 3).
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A different outcome was observed after irradiation with 10 Gy. For the radiation sensitive
cells three out of the ten top pathways were linked to apoptotic processes with the genes BBC3,
BCL2, TP53 as key players, whereas for the normal sensitive cell line we mainly observed the
induction of senescence related pathways. This indicates that different doses are necessary to
induce a similar response in the two cell lines. The activation of senescence genes is a damage
response mechanism, which stably arrests proliferating cells and protects them from apoptotic
cell death [36]. Together with the senescence pathway we observed increased levels of chemo-
kine, cytokine and interleukin genes that are known to activate an immune response and signal
transduction pathways in response to irradiation.
Although the senescence-associated pathways were not seen as the most important ones for
the treatment condition 10 Gy/increased sensitivity, they were significantly enriched in the
GANs of the three conditions 1 Gy/increased sensitivity, 10 Gy/ increased sensitivity and 10
Gy/normal sensitivity. All differentially expressed genes that related to senescence-associated
pathways are shown in supplementary S5 Table. The observation that cells with increased radi-
ation sensitivity compared to cells with normal sensitivity, become senescent after exposure to
doses in the range of 1 Gy, rises the question whether this has a positive or negative influence on
the tumor therapy. On the one hand side, senescent cell may secret the so-called SASP (“senes-
cence-associated secretory phenotype“) factors, including growth factors, chemokines and cyto-
kines, which participate in intercellular signaling leading to the attraction of immune cells to the
tumor location that, in turn, eliminate the tumor cells and, thereby, positively contribute to the
tumor therapy [37, 38]. On the other hand side, senescent cells and the SASP are reported to pro-
mote proliferation, survival, invasion and migration of neighboring cells by the release of pro-
inflammatory cytokines leading to sustained inflammation [36]. In this way senescence cells can
damage their local environment and stimulate angiogenesis and tumor progression [39, 40].
Besides, there are some evidences that the induction of senescence in surrounding normal tissue
may lead to an increased radio-tolerance or even radioresistance of the tumor and is, therefore,
not desirable and negatively influences the tumor radiotherapy [41]. Thus, it might be beneficial
to block senescence in order to prevent the radio-hyposensibilization of tumor cells. Therefore,
we suggest a detailed investigation of the consequences of senescent non-tumor cells with the
aim to improve the radiotherapy of tumors in radiosensitive patients.
Identification of senescence associated genes involved in cell radiation
responses
CDKN1A gene was identified as one of the most important key players linked to the identified
senescence associated pathways for both 1 Gy/sensitive and 10 Gy/normal treatment condi-
tions. For both conditions the expression of the CDKN1A was up-regulated for all considered
time points. CDKN1A is a well-known damage response gene for which aberrant transcrip-
tional response has been associated with abnormal sensitivity to ionizing radiation [42, 43].
The study by Badie et al. (2008) has shown that a subgroup of breast cancer patients, who
developed severe reactions to radiation therapy, could be identified by aberrant overexpression
of CDKN1 in peripheral blood lymphocytes [43].
LMNB1 is another genes we identified as a response hub gene after irradiation of sensitive
cell line with 1 Gy radiation dose that is associated with senescence. Although the LMNB1 gene
was not identified as hub gene in the GAN of the 10 Gy/normal treatment condition, it was still
differentially expressed. For both treatment conditions we observed significant downregulation
of this gene 24 hours after irradiation. Shah et al (2013) has suggested that downregulation of
LMNB1 in senescence is a key trigger of chromatin changes affecting gene expression [44]. In
fact also in our data we observed strong downregulation of a group of histone genes associated
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with senescence (S5 Table) for the treatment conditions 1 Gy/increased sensitivity and 10 Gy/
normal sensitivity. Furthermore, Lee et al. (2012) has shown that histone protein modification
may have an impact on the radiation sensitivity of a tissue [45]. Moreover, evidence has been
provided that mutation of LMNA can cause increased sensitivity to ionizing radiation [46],
however, to our knowledge there are no data showing the role of LMNB gene in the context of
radiation sensitivity.
Another potential therapeutic candidate associated with senescence that was identified for
the 10 Gy/normal sensitivity treatment condition was MRE11A for which cell culture data sug-
gest that treatment of cells with Mre11 siRNA increases radiation sensitivity and reduces heat-
induced radiosensitization [47, 48]. However, the clinical applicability of MRE11, has not been
confirmed [49].
Assessment of the false positive rate and validation of the NCSRM
method
The spline regression based differential analyses between technical replicates were performed
in order to estimate the extent of random fluctuations of gene expression values. The detected
3% rejections of the overall null hypothesis of no differential gene expression are in accordance
with the alpha-level of 5% of the familywise error rate (FWER) and can be considered as false
positives. On the other hand, it shows that type I error, due to technical variation, is covered by
the model and test assumptions (moderated F-test, [50]) so that it was not necessary to include
an extra parameter for technical replicates into the model.
In order to validate the previously mentioned biological results using NCSRM, we per-
formed the differential expression analysis with another established method for time-course
data analysis called BETR (Bayesian Estimation of Temporal Regulation) [6]. The number of
genes detected by BETR was considerably lower compared to NCRSM (Table 1), however the
majority of which were also detected with NCSRM (S1 Table). This is in line with the calcula-
tions on the false positive rates that have been conducted on the simulated data presented in
the BETR study. In an analysis of the simulated data set, 65% of truly differentially expressed
genes have been identified after accepting a false positive rate of 5% [6]. This means that a sub-
stantial proportion of differentially expressed genes remained undetected, which is likely to be
also the case for the herein analyzed data with BETR. Although the numbers of differentially
expressed genes and genes remained in the reconstructed networks greatly differ (Table 1), the
qualitative results are well comparable (Table 3). For all treatment conditions where for which
we were able to reconstruct GANs, we observed a great overlap of pathways where the 5% of
hub genes were mapped to (Table 3). The detection of a higher number of differentially
expressed genes with NCSRM resulted in larger GANs with additional information compared
to the smaller GANs that were reconstructed on the basis of genes detected with BETR. This is
underlined by the results of the conducted evaluation of GANs. Except one network based on
the differentially expressed genes using BETR, all investigated networks consist significantly
more common edges with the Reactome reference network compared to random networks
with identical network topology and genes. This shows that the additionally detected genes
with NCSRM add additional information rather than adding false positives or noise to the set
of differentially expressed genes. Moreover the spline regression method is much more flexible
and allows for more freedom during the data collection process. As already mentioned,
NCSRM does not require the same sampling time for treated and control groups and can easily
deal with incomplete data, whereas BETR method is not able to overcome or bypass those limi-
tations. Thus, NCSRM is very robust against the frequently occurring shortcomings in study
design and subsequent data generation occurring in life sciences.
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Conclusion
Prospectively, we suggest and plan a detailed in silico and in vitro analysis of the interactions in
the proposed gene association networks in order to add meaningful knowledge to the mecha-
nism of radiosensitivity at the experimental level. This novel knowledge has the potential to
improve cancer radiation therapy by preventing or lowering the acute responses of normal
cells resulting from radiation therapy. The results add novel information to the understanding
of mechanisms that are involved in the radiation response of human cells, with the potential to
improve tumor radiotherapy. Besides, the presented workflow is not limited to presented study
only, but may be applied in other special fields with different biological questions to be
addressed.
The software is provided as R-package “splineTimeR” and freely available via the Biocon-
ductor project at http://www.bioconductor.org.
Material and Methods
Cell culture
Experiments were conducted with two monoclonal lymphoblastoid Epstein-Barr virus-immor-
talized cell lines (LCL) obtained from young lung cancer patients of the LUCY study (LUng
Cancer in Young) that differ in radiosensitivity, as tested with Trypan Blue and WST-1 assays
[19, 20]. The non-cancer cell lines LCL 4060–200 with increased radiation sensitivity and LCL
20037–200 with normal radiation sensitivity were cultured at 37°C/5% CO2 in RPMI 1640
medium (Biochrom) supplemented with 10% fetal calf serum (FCS; PAA). Mycoplasma con-
tamination was routinely tested using luminescence-based assays (MycoAlert, Lonza).
Irradiation and sample preparation
The cells were seeded in 75 cm2 flasks at a concentration of 0.5 x 106 cells/ml in a total volume
of 60 ml. Exponentially growing cells were irradiated with sham, 1 Gy and 10 Gy of gamma-
irradiation (137Cs-source HWM-D 2000, Markdorf, Germany) at a dose rate of 0.49 Gy/min.
Samples were collected 0.25, 0.5, 1, 2, 4, 8 and 24 hours after sham or actual irradiation.
Between the time of collection cells were kept in the incubator. Collected cells were washed
with PBS and frozen at -80°C. Total RNA was isolated from frozen cell pellets obtained from
two independent experiments using the AllPrep DNA/RNA/miRNA Universal Kit (Qiagen)
including an DNase digestion step, according to the manufacturer's protocol. The concentra-
tion of RNA was quantified with a Qubit 2.0 Fluorometer (Life Technologies), and integrity
was determined using a Bioanalyzer 2100 (Agilent Technologies). RNA samples with a RNA
integrity number (RIN) greater than 7 indicated sufficient quality to be used in subsequent
RNA microarray analysis.
Gene expression profiling
Transcriptional profiling was performed using SurePrint G3 Human Gene Expression 8x60k
V2 microarrays (Agilent Technologies, AMADID 39494) according to the manufacturer’s pro-
tocol. 75 ng of total RNA was used in labeling using the Low Input Quick Amp Labeling Kit
(one-color, Agilent Technologies). Raw gene expression data were extracted as text files with
the Feature Extraction software 11.0.1.1 (Agilent Technologies). The expression microarray
data were uploaded to ArrayExpress (www.ebi.ac.uk/arrayexpress/) and the data set is available
under the accession number E-MTAB-4829. All data analysis was conducted using the R statis-
tical platform (version 3.2.2, www.r-project.org) [51]. Data quality assessment, filtering, pre-
processing, normalization, batch correction based on nucleic acid labeling batches and data
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analyses were carried out with the Bioconductor R-packages limma, Agi4x44PreProcess and the
ComBat function of the sva R-package [4, 21, 52]. All quality control, filtering, preprocessing and
normalization thresholds were set to the same values as suggested in Agi4x44PreProcess R-pack-
age user guide [21]. Only HGNC annotated genes were used in the analysis. For multiple micro-
array probes representing the same gene the optimal probe was selected according to the
Megablast score of probe sequences against the human reference sequence (http://www.ncbi.
nlm.nih.gov/refseq/) [53]. If the resulted score was equal for two or more probes, the probe with
the lowest differential gene expression FDR value was kept for further analyses since only one
expression value per gene was allowed in subsequent GAN reconstruction analysis.
Spline regression model for two-way experimental design
A natural cubic spline regression model (NCSRM) with three degrees of freedom for an experi-
mental two-way design with one treatment factor and time as a continuous variable was fitted
to the experimental time-course data. The mathematical model is defined by the following eq
(1):
y ¼ yðt; xÞ
¼ b0 þ b1B1ðt  t0Þ þ b2B2ðt  t0Þ þ . . .þ bmBmðt  t0Þ þ xðd0 þ d1B1ðt  t0Þ þ d2B2ðt
 t0Þ þ . . .þ dmBmðt  t0ÞÞ
where b0, b1, . . ., bm are the spline coefﬁcients in the control group and d0, d1, . . ., dm are differ-
ential spline coefﬁcients between the control and the irradiated group. B1(t-t0), B2(t-t0), . . .,
Bm(t-t0) are the spline base functions and t0 is the time of the ﬁrst measurement. For x = 0,
y = ycontrol and for x = 1, y = yirradiated. For three degrees of freedom (df = 3), m = 3.
Depending on the number of degrees of freedom, two boundary knots and df-1 interior knots
are specified. The interior knots were chosen at values corresponding to equally sized quantiles of
the sampling time from both compared groups. For example, for df = 3 interior knots correspond
to the 0.33- and 0.66-quantiles. The spline function is cubic on each defined by knots intervals,
continuous at each knot and has continuous derivatives of first and second orders.
Time-course differential gene expression analysis
The time-course differential gene expression analyses were conducted between irradiated and
control cells (sham-irradiated). Analyses were performed on the normalized gene expression
data using NCSRMwith three degrees of freedom. The splines were fitted to the real time-course
expression data for each gene separately according to eq (1). The example of spline regression
model fitted to the measured time-course data for one selected gene is shown on the Fig 2.
Time dependent differential expression of a gene between the irradiated and corresponding
control cells was determined by the application of empirical Bayes moderated F-statistics [50]
on the differential coefficients values in eq (1). In order to account for the multiple-testing
error, corresponding p-values were adjusted by the Benjamini-Hochberg method for false dis-
covery [22]. Genes with an adjusted p-value (FDR, false discovery rate) lower than 0.05 were
considered as differentially expressed and associated with radiation response.
Assessment of the false positive rate of the NCSRM
Additionally, in order to assess the false positive rate (statistical type I error, also called familywise
error rate or FWER) we applied differential gene expression analysis using NCSRM between two
technical replicates for all treatment groups. Because only two technical replicates were generated
for each time point and treatment, we could not use the same approach to assess the technical vari-
ability for the BETRmethod, as it requires at least two replicates in each compared groups.
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Gene association network reconstruction from prior selected
differentially expressed genes
Differentially expressed genes were subjected to gene association network reconstruction from
time-course data using a regularized dynamic partial correlation method [54]. Pairwise rela-
tionships between genes over time were inferred based on a dynamic Bayesian network model
with shrinkage estimation of covariance matrices as implemented in the GeneNet R-package
available from CRAN [18]. Analyses were conducted with a posterior probability of 0.95 for
each potential edge. Edge directions were not considered. In order to assess the complexity of
the resulting networks, the density of each network was compared to the density of the Reac-
tome functional interaction network [35, 55].
Identification of important nodes in the network
Graph topological analyses based on centrality measures were applied in order to determine
the importance of each node in the reconstructed association networks [56]. Three most
Fig 2. Example of fitted spline regression models. The plot shows spline regression models fitted to the
measured time-course expression data of an arbitrary chosen gene (BBC3). The blue line represents the fitted
model for the control (0 Gy) and read line that for the irradiated group (1 Gy). Blue and red dots represent the
measured expression levels of the biological replicates. Vertical lines represent the endpoints and interior knots
correspond to the 0.33- and 0.66-quantiles.
doi:10.1371/journal.pone.0160791.g002
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commonly used centrality measures: degree, shortest path betweenness and closeness were
combined into one cumulative centrality measure [34]. For each gene the three centrality val-
ues where ranked. The consensus centrality measure for each node was defined as the mean of
the three independent centrality ranks. Combining centrality measures supports the identifica-
tion of the nodes that are central themselves and also connected to direct central nodes, which
demonstrates strategic positions for controlling the network.
Pathway enrichment analysis
The Reactome pathway database was used to conduct the pathway enrichment analysis in
order to further investigate the functions of the selected sets of differentially expressed genes
[35]. Statistical significance of enriched pathways was determined by one-sided Fisher's exact
test. The resulting p-values were adjusted for FDR using the Benjamini-Hochberg method.
Pathways with FDR<0.05 were considered statistically significant and pathways were ranked
according to ascending FDRs.
Evaluation of NCSRM approach
Since we decided to use the set of genes that appeared to be differentially expressed we assessed
the performance of the herein used NCSRM approach in comparison to the BETR approach
implemented in the R/Bioconductor package betr [6]. BETR is a well-established algorithm
that has been previously compared to limma, MB-statistic and EDGE methods and showed the
best performance [6]. The results of spline and BETR methods were compared using the same
initial microarray gene expression data set. The probabilities of each gene to be differentially
expressed obtained with BETR method, were transformed to p-values as described in the origi-
nal paper. Genes were considered significantly differentially expressed if the Benjamini-Hoch-
berg adjusted p-value was lower than 0.05 (FDR<0.05). This transformation allowed us to
compare the outcomes of both methods based on the FDR values for differential expression.
The resulting differentially expressed genes using BETR were analyzed and subjected to net-
work reconstruction as described above for the differentially expressed genes obtained using
NCSRM. Outcomes of both obtained association networks were compared to each other and to
the a priori known biological network provided by the Reactome database [35].
Evaluation of reconstructed gene association networks
In order to assess the quality of the de novo reconstructed gene association networks (GANs),
we developed a novel method that compares the interactions in the reconstructed network to
the experimentally validated interactions present in the Reactome interaction network. For this
purpose we used the Reactome reference network, consisting of protein-protein interaction
pairs stored in the Reactome database (http://www.reactome.org/pages/download-data/). For
the comparison, sub-networks of reconstructed networks consisting only of genes overlapping
with the Reactome network were built. The number of common edges between these two sub-
networks was determined and referred to the total number of edges in the reconstructed net-
work (percentage of common edges in the reconstructed network). Further, a permutation test
was performed to assess whether the number of common edges in the reconstructed network
was significantly higher than in randomized networks with the same genes. Random networks
were generated by permutation of the node names in the network, while preserving the recon-
structed sub-network topology. After each permutation (n = 1000) the number of common
edges with the reference Reactome sub-network was determined. The reconstructed network
was considered significantly better than random, if more than 90% of the random sub-net-
works contained lower numbers of edges common with the Reactome network than the
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reconstructed sub-network (p-value< 0.1). All networks reconstructed with the genes deter-
mined as differentially expressed from the herein presented spline regression method and the
BETR method were evaluated.
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(XLSX)
S5 Table. Significantly enriched senescence associated pathways with corresponding differ-
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Abstract
Background: Acquired and inherent radioresistance of tumor cells is related to tumor relapse and poor prognosis –
not only in head and neck squamous cell carcinoma (HNSCC). The underlying molecular mechanisms are largely
unknown. Therefore, systemic in-depth analyses are needed to identify key regulators of radioresistance. In the
present study, subclones of the CAL-33 HNSCC cell line with different radiosensitivity were analyzed to identify
signaling pathways related to the different phenotypes.
Methods: Subclones with altered radiosensitivity were generated by fractionated irradiation of the parental
CAL-33 cells. Differences in radiosensitivity were confirmed in colony formation assays. Selected subclones
were characterized at the genomic and transcriptomic level by SKY, array CGH, and mRNA-microarray analyses.
Time-course gene expression analyses upon irradiation using a natural cubic spline regression model identified
temporally differentially expressed genes. Moreover, early and late responding genes were identified. Gene
association networks were reconstructed using partial correlation. The Reactome pathway database was
employed to conduct pathway enrichment analyses.
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Results: The characterization of two subclones with enhanced radiation resistance (RP) and enhanced radiosensitivity
(SP) revealed distinct genomic and transcriptomic changes compared to the parental cells. Differentially expressed
genes after irradiation shared by both subclones pointed to important pathways of the early and late radiation
response, including senescence, apoptosis, DNA repair, Wnt, PI3K/AKT, and Rho GTPase signaling. The analysis of
the most important nodes of the gene association networks revealed pathways specific to the radiation response
in different phenotypes of radiosensitivity. Exemplarily, for the RP subclone the senescence-associated secretory
phenotype (SASP) together with GPCR ligand binding were considered as crucial. Also, the expression of endogenous
retrovirus ERV3-1in response to irradiation has been observed, and the related gene association networks have been
identified.
Conclusions: Our study presents comprehensive gene expression data of CAL-33 subclones with different radiation
sensitivity. The resulting networks and pathways associated with the resistant phenotype are of special interest and
include the SASP. The radiation-associated expression of ERV3-1 also appears highly attractive for further studies of
the molecular mechanisms underlying acquired radioresistance. The identified pathways may represent key players
of radioresistance, which could serve as potential targets for molecularly designed, therapeutical intervention.
Keywords: Radioresistance, HNSCC, Head and neck cancer, Time-course gene expression, Gene association network,
Signaling pathway, Differentially expressed genes, Endogenous retrovirus
Background
Head and neck squamous cell carcinoma (HNSCC) de-
velops in approx. 139,000 individuals per year in Europe
with a survival rate of approx. 70 % at 1 year and approx.
40 % at 5 years after therapy [1]. More than 90 % of head
and neck cancers are classified as HNSCC and originate
from the oral cavity, nasopharynx, oropharynx, hypopha-
rynx, or larynx, respectively [2]. The major risk factors for
HNSCC are tobacco smoking, alcohol abuse, and poor
oral health [3, 4]. For oropharyngeal cancers, infection
with high-risk human papilloma viruses is another impor-
tant risk factor [5]. Thus, HNSCC is a very heterogeneous
cancer entity also in terms of therapy response. Surgical
resection followed by radio(chemo)therapy is the standard
treatment of HNSCC patient [6, 7]. In locally advanced
HNSCC, surgery is often limited by the complex anatomy
of the affected region and, therefore, definitive radioche-
motherapy is an important treatment option. However,
acquired and/or inherent radioresistance of tumor cells is
a common cause for tumor relapse and poor prognosis.
Tumor cells derived from HNSCCs after radiotherapy
have been reported to be more radioresistant than cell
lines established prior to therapy, thus strengthening the
clinical relevance of acquired radioresistance [8]. Along
these lines, it was proposed that fractionated irradiation
might preferentially eradicate radiosensitive cells, whereas
radioresistant cells remain largely untouched. Accordingly,
recurrent tumors mostly consist of radioresistant cells [8].
Although different potential mechanisms of radioresis-
tance have been proposed and extensively studied, the
underlying molecular details remain largely unknown [9].
Systemic in-depth analyses are needed in order to identify
the master regulators of acquired radioresistance, which
could serve as potential biomarkers and future therapeutic
targets in novel combined modality approaches.
In this study, we characterized two subclones (#303
and #327) derived from the CAL-33 HNSCC cell line,
which were generated by fractionated radiation treat-
ment of the parental cells. CAL-33 is an HPV-negative
HNSCC cell line that has been established by Gioanni et
al. (1988) from a biopsy specimen prior to treatment
from a squamous cell carcinoma of the tongue from a
male patient [10]. The subclones derived thereof differed
in radiosensitivity when compared to the parental CAL-
33 cell line. Interestingly, one subclone was significantly
more radioresistant, whereas the other one was signifi-
cantly more radiosensitive. In order to identify potential
key regulators of altered radiation sensitivity, the subclones
were characterized on the genomic and transcriptomic
level. Furthermore, time-course gene expression analyses
were performed upon irradiation, and gene association
network reconstruction and pathway enrichment analyses
were utilized to identify signaling pathways related to the
observed radiation phenotypes.
Methods
Cell culture
The human head and neck squamous cell carcinoma
(HNSCC) cell line CAL-33 was obtained from the
German collection of microorganisms and cell cultures
(DSMZ). Cells were maintained in DMEM GlutaMAX I
medium supplemented with 10 % FCS and 1 % penicillin/
streptomycin and cultured at 37 °C/5 % CO2. Cells were
mycoplasma-free as tested by the MycoAlert (Lonza)
mycoplasma detection kit.
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Generation of clones with altered radiation resistance
In order to generate radioresistant subclones of the par-
ental CAL-33 cell line, exponentially growing CAL-33
cells were exposed to fractionated irradiation (Mueller
RT-250 γ-ray, tube Thoraeus Filter, 200 kV, 10 mA)
according to a schedule commonly used in radiotherapy:
A total dose of 20 Gy was given in daily fractions of
2 Gy 5 times per week. For each week, 2 days of recov-
ery time were included. Afterwards, cells were cloned by
limiting dilution procedure and grown for 4 to 12 weeks.
Colony forming assay
Clonogenic survival was determined in colony formation
assays as described previously [11]. Briefly, cells were
seeded into 6-well plates, allowed to adhere for 4 h, and
irradiated at 0, 1, 2, 4, 6 or 8 Gy, respectively (Mueller RT-
250 γ-ray, Thoraeus Filter, 200 kV, 10 mA). 14 days after
irradiation, colonies were fixed and stained with methy-
lene blue. Only colonies consisting of at least 50 cells were
scored. Each assay was carried out in duplicates of three
different cell densities per each irradiation dose. Results
from three independent experiments were subjected to
linear-quadratic regression analyses employing the max-
imum likelihood approach. Differences between curves
were evaluated using F-test [12].
Proliferation and cell cycle analyses
Proliferation rates were determined over a period of three
days upon seeding 20,000 cells per well into 24-well plates.
Cells were harvested by trypsinization, and total cell
numbers were determined by manual counting. Cell num-
bers were plotted against the growth time, and doubling
times were calculated by semi-log regression analyses in
the exponential growth phase. Dynamics of cell cycle
distribution upon irradiation at 4 Gy was analyzed by flow
cytometric phospho-histone H3(S10)/propidium iodide
(PI) staining as described in [13]. Briefly, cells were
collected by trypsinization and fixed in 70 % ethanol. After
extensive washing, cells were stained with anti-phospho-
histone-H3-Alexa488 (pH3(S10)) antibody (New England
Biolabs, Frankfurt, Germany) and PI/RNase staining
solution (BD Biosciences, Heidelberg, Germany). Data of
10,000 cells were recorded on an LSRII flow cytometer
(BD Biosciences), and cell cycle analyses were performed
by using FlowJo 7.6.5 software (Tree Star Inc., Ashland,
OR, USA).
Spectral karyotyping (SKY)
Metaphase chromosome spreads were prepared from un-
treated CAL-33 parental cell line and generated CAL-33
sublines. Colcemid (Roche) was added at a final concen-
tration of 0.1 μg/ml to the culture medium of exponen-
tially growing cells at a density of 6 × 106 cells per 75 cm2.
After 3 h of incubation time, cells were washed with PBS,
trypsinized, suspended in fresh culture medium followed
by hypotonic KCl treatment (75 mM) at 37 °C for 25 -
minutes. Following centrifugation, cells were resuspended
in 2–3 ml of fixation solution and approximately 40–50 μl
of cell suspension was dropped on several microscope
slides. After one week of ageing at room temperature,
spectral karyotyping was performed as described by
Hieber et al. [14]. The karyotype of each cell line was
determined based on a minimum of 15 metaphases.
Chromosomal aberrations were detectable by color junc-
tions within affected chromosomes. Spectral imaging and
image analysis were performed with a SpectraCube system
and SkyView imaging software (both from Applied Spec-
tral Imaging).
Genomic copy number typing (array CGH)
In order to characterize copy number changes of parental
CAL-33 and generated CAL-33 sublines, array compara-
tive genomic hybridization analysis (array CGH) was
performed on high-resolution oligonucleotide-based Sure-
Print G3 Human 180 k CGH microarrays (AMADID
252206, Agilent Technologies). DNA from non-irradiated
samples was isolated using the QIAamp DNA Mini Kit
(Qiagen). The DNA concentration was quantified with the
NanoDrop 1000 Spectrophotometer (Thermo Fisher
Scientific, Germany). Slight modifications of the original
Agilent array CGH protocol were introduced. 250 ng
isolated cell line DNA and 250 ng sex-mismatched normal
reference DNA (Promega) were labeled with Cy3 and Cy5,
respectively, using the CGH labeling kit for oligo arrays
(Enzo) following the Enzo’s protocol. Microcon YM-30
columns (Millipore) were used to remove the unincorpo-
rated nucleotides. Subsequent labeled DNA hybridization,
washing and scanning of the CGH arrays were continued
according to the Agilent’s protocol. The fluorescence
intensities were extracted as text files with the Feature
Extraction software 10.7 (Agilent Technologies). Obtained
data were imported into the R statistical platform (version
3.2.2, www.r-project.org) and filtered for quality outliers
using the QA measurements generated by the Feature
Extraction software. Experimental artifacts were removed
from the array CGH data using spatial normalization as
suggested and described in MANOR R-package manual
[15] and [16]. Array CGH profiles containing a wave bias
that appear as waves in plots were removed using ridge
regression based algorithms implemented in NoWaves
R-package available from http://www.few.vu.nl/~mavd
wiel/nowaves.html [17]. Following normalization and/
or wave bias removal, data were segmented using circular
binary segmentation algorithms as implemented in DNA-
copy R-package [18] in order to detect breakpoints and
levels in single array CGH profiles [19]. Chromosomal
gains and losses were determined using CGHcall algo-
rithm implemented in CGHcall R-package [20]. To reduce
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data complexity, copy number calls were transformed into
regions using the R-package CGHregions [21].
Irradiation and sample preparation
Cells were seeded into 6-well plates and allowed to adhere
for 16 h. The numbers of plated cells were adjusted to the
incubation times: For samples collected 0.25, 2, 7, 12, and
24 h after irradiation, 3.5 × 105 cells/well were seeded,
whereas for those collected after 48, 72, and 96 h, 1.75 ×
105 cells/well were used. Cells were irradiated at 0 or 8 Gy
of gamma-irradiation (Mueller RT-250, Thoraeus Filter,
200 kV, 10 mA) at a dose rate of 1.3 Gy/min, and samples
were collected after 0.25, 2, 7, 12, 24, 48, 72, and 96 h by
scraping on ice. The washed, dry cell pellet was snap
frozen and stored at −80 °C. Samples from 3 independent
experiments were used for subsequent transcriptomic
analyses. Total RNA was isolated using the Rneasy Mini
Kit (Qiagen) including a DNase digestion step, according
to the manufacturer’s protocol. The concentration of RNA
was quantified with a Qubit 2.0 Fluorometer (Life
Technologies), and RNA integrity was confirmed with a
Bioanalyzer 2100 (Agilent Technologies). Samples with
RNA integrity number (RIN) >7 were used in subsequent
gene expression microarrays analyses.
Global gene expression profiling
Global gene expression profiling of all CAL-33 cell lines
was performed on SurePrint G3 Human Gene Expression
8x60k microarrays (Agilent Technologies, AMADID
28004) using 60 ng of total RNA according to the manu-
facturer’s protocol (one-color Low Input Quick Amp
Labeling Kit, Agilent Technologies). Raw gene expression
data were extracted as text files with the Feature Extraction
software 11.0.1.1 (Agilent Technologies). All data analysis
was conducted using the R statistical platform (version
3.2.2, www.r-project.org) [22]. Data quality assessment,
filtering, preprocessing, normalization, batch correction
based on nucleic acid labeling batches and data analyses
were carried out with the Bioconductor R-packages limma,
Agi4x44PreProcess and the ComBat function of the
sva R-package [23–25]. All quality control, filtering, pre-
processing and normalization thresholds were set to the
same values as suggested in Agi4x44PreProcess R-package
user guide [25]. Only HGNC annotated genes were used
in the analysis. For multiple microarray probes represen-
ting the same gene the optimal probe was selected accor-
ding to the Megablast score of probe sequences against
the human reference sequence (http://www.ncbi.nlm.nih.
gov/refseq/) [26]. If the resulted score was equal for two
or more probes, the probe with the lowest differential
gene expression FDR value was kept for further analyses
since only one expression value per gene was allowed in
subsequent gene association network (GAN) reconstruc-
tion analysis.
Differential gene expression analysis
The time-course differential gene expression analyses
were conducted between irradiated and control cells
(sham-irradiated) using a natural cubic spline regression
model with three degrees of freedom as described in
splineTimeR R-package [27]. Obtained p-values were
adjusted by the Benjamini-Hochberg method for false
discovery [28]. Genes with an adjusted p-value (FDR,
false discovery rate) lower than 0.05 were considered as
differentially expressed and associated with radiation
response. For the status quo experiment that compares
the derived CAL-33 clones with the parental CAL-33 cell
line, genes were considered as differentially expressed
when a log2 fold-change was higher than 0.5 and a FDR
value lower than 0.05.
Identification of early and late responding genes
Temporally differentially expressed genes with fold-change
above 2.0 or below 0.5 in any measured time points within
the first day after irradiation were considered as early
responding genes. Respectively, genes with fold-change
above 2.0 or below 0.5 within the second, third or fourth
day of irradiation were considered as late responding.
Gene association network reconstruction and
identification of important nodes in the reconstructed
networks
Temporally differentially expressed genes were subjected
to gene association network (GAN) reconstruction using
a regularized dynamic partial correlation method [29].
Pairwise relationships between genes over time were
inferred based on a dynamic Bayesian network model
with shrinkage estimation of covariance matrices as
implemented in the GeneNet R-package [30]. Analyses
were conducted with a posterior probability of 0.95 for
each potential undirected edge. Further, in order to deter-
mine the importance of each node in the reconstructed
association networks, graph topological analyses based on
centrality measures were applied [31]. Three most com-
monly used centrality measures: degree, shortest path
betweenness and closeness describing the importance of
gene in a network were combined into one centrality
measure [32]. For each gene the three centrality values
where ranked and the consensus centrality measure for
each node was defined as the mean of the three indepen-
dent centrality ranks.
Pathway enrichment analysis
The Reactome pathway database was used to conduct
the pathway enrichment analysis in order to further
investigate the functions of the selected sets of differen-
tially expressed genes [33]. Only pathways containing
not more than 600 genes and not less than 20 genes were
considered. Thereby, too general and too specific pathways
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were excluded from the analysis. Statistical significance of
enriched pathways was determined by one-sided Fisher’s
exact test. The resulting p-values were adjusted for FDR
using the Benjamini-Hochberg method.
qRT-PCR technical validation of gene expression data
For technical validation of the gene expression microarray
data, RNA samples (500 ng) were reversely transcribed
using the QuantiTect Reverse Transcription Kit (Qiagen)
according to the manufacturer’s protocol and subjected to
qRT-PCR reactions (10 μl) on a ViiA 7 qPCR system (Life
Technologies). The following Taqman® Assays were used
(Life Technologies): AKT3 (Hs00987350_m1), GADD45A
(Hs01077132_m1), MAL (Hs00360838_m1), HOPX (Hs0
4188695_m1), HYAL3 (Hs00185910_m1), TUBGCP3 (Hs
00902139_m1), RGS16 (Hs00892674_m1), TNFAIP3 (Hs0
0234713_m1). ACTB (Hs01060665_g1) and GAPDH (Hs9
9999905_m1) served as endogenous reference genes.
Relative expression levels were calculated using the ΔΔCt
method and Spearman correlation analyses with micro-
array data were performed. Validation was considered
successful for Spearman’s rho > 0.5. Additionally, the fold-
change values obtained from microarrays and qRT-PCR
were compared.
Results and discussion
Tumor relapse after radiochemotherapy in HNSCC is often
linked to intrinsic and/or acquired radioresistance of tumor
cells. However, the underlying molecular mechanisms
remain largely unknown [9]. To gain knowledge on this
fundamental and clinically relevant process, we established
an in vitro model of acquired phenotypes of discrepant
radiosensitivity in CAL-33 cells. The underlying molecular
mechanisms were investigated by static and dynamic global
mRNA expression analyses with subsequent network re-
construction and pathway enrichment analyses.
CAL-33 subclones with different phenotypes of
radiosensitivity and cytogenetic characteristics
The parental cell line CAL-33 was repeatedly irradiated in
order to generate subclones with different phenotypes of
radiosensitivity. To analyze acquired alterations in radio-
sensitivity of the derived CAL-33 subclones, long-term
survival upon gamma-irradiation was assessed by colony
formation assays (Fig. 1). For further analyses we selected
two subclones. Both subclones #303 and #327 showed
statistically significant differences (p-values < 0.0001) when
compared to the parental CAL-33 cells. Interestingly, sub-
clone #303 showed increased radiosensitivity (sensitive
Fig. 1 Dose-survival curves of parental CAL-33 cell line and derived subclones. The linear-quadratic cell survival curves were fitted to the measured
data using maximum-likelihood method. Both subclones (SP and RP) showed statistically significant difference (p-values < 0.0001) in response to
ionizing radiation compared to the parental CAL-33 cell line
Michna et al. Radiation Oncology  (2016) 11:94 Page 5 of 16
Publication II 48
phenotype, SP), whereas subclone #327 was more radio-
resistant (resistant phenotype, RP) – particularly in the
dose range > 4 Gy.
At first glance, the emergence of more radiation sensi-
tive subclones appears unexpected and might be related to
clonal evolution that was initiated by the irradiation-
induced genomic alterations and that might occur at sub-
lethal doses. This phenomenon has also been observed in
previous studies [34, 35]. In comparison to other HNSCC
cell lines, CAL-33 is very radioresistant a priori and this
might explain why it appears to be very difficult to gene-
rate subclones with an even more resistant phenotype.
To analyze structural and numerical chromosomal
aberrations in comparison to the parental cell line, the
subclones were cytogenetically characterized by SKY ana-
lyses. Structural and numerical aberrations identified by
SKY in the parental CAL-33 cell line involved chromo-
somes 3, 7, 8, 9, 16, 18, 20, X, and Y (Fig. 2a). Structural
and numerical aberrations of the SP subclone included
chromosomes 2, 3, 7, 8, 9, 11, 16, 18, 20, 21, X, and Y
(Fig. 2b). Chromosomes 1, 3, 4, 5, 7, 8, 9, 14, 16, 18, 20, X,
and Y were affected by aberrations in subclone RP (Fig. 2c).
The obtained SKY results were complemented with
copy number analysis by array CGH (Fig. 3 and Additional
file 1: Table S1). Array CGH analysis identified 173 regions
with aberrant copy number status from which 78, 111 and
132 regions were affected by DNA gains or DNA losses in
the CAL-33 parental cells, SP, or RP subclones, respec-
tively (Fig. 3 and Additional file 1: Table S1 and Additional
file 2: Table S2). 68 copy number alterations (for SP) and
85 copy number alterations (for RP) were different from
the parental CAL-33 cell line. Cytogenetic studies of both
clones showed distinct genomic changes in comparison to
the parental cell line indicating genomic key alterations
for irradiation-related phenotypes on chromosomes 1, 2,
3, 4, 5, 8, 11, 14, 16 and 21. In addition, recurrent CAL-
33-specific alterations on chromosomes 3, 7, 18, X and Y
were observed showing the authenticity of the newly
generated cell lines.
Analysis of proliferation rates and cell cycle distribution
Proliferation rate and cell cycle distribution are impor-
tant factors, which can affect radiosensitivity and/or
resistance. Accordingly, we performed proliferation and
cell cycle analyses. In comparison to CAL-33 parental
cells, both subclones displayed prolonged doubling times
(29 h for subclone SP, 30 h for subclone RP, and 24 h for
the parental cell line, Additional file 3: Figure S1, A).
This might be due to the observation that under expo-
nential growth conditions, the percentage of mitotic cells
in both subclones was decreased (2.1 % for subclone SP,
1.5 % for subclone RP, and 2.9 % for the parental cells),
but fails to explain the differences in radiosensitivity
(Additional file 3: Figure S1, B). With regard to irradiation-
induced G2-arrest, the sensitive subclone SP revealed
virtually identical dynamics as the parental CAL-33 cells,
whereas in the resistant subclone RP G2-arrest was initially
delayed, but also reached its maximum around 12 h after
irradiation, and afterwards appeared to be prolonged
(Additional file 3: Figure S1, C). In fact, prolonged cell
cycle arrest can contribute to radioresistance as cells have
more time to repair irradiation-induced DNA damage.
However, extended cell cycle arrest can also be indicative
for delayed DNA repair. In order to address the mecha-
nisms underlying radioresistance on a molecular level,
next we therefore performed unbiased transcriptome ana-
lyses of the CAL-33 subclones.
mRNA gene expression analysis of the CAL-33 subclones
Microarray analyses allowed the identification of diffe-
rences in basal gene expression levels between the derived
subclones and the parental CAL-33 cell line. We identified
523 and 1292 differentially expressed genes (FDR < 0.05)
for clones SP and RP, respectively, whereas 361 of the
genes were overlapping (Additional file 4: Table S3). It is
interesting to note that the RP clone exhibited more
pronounced transcriptional differences than the SP clone.
Eight of the differentially expressed genes (SP and/or RP
clone versus the parental CAL-33 cell line) were arbitrarily
chosen for technical validation of the microarray data. Cor-
relation analysis between qRT-PCR and microarray data
showed a strong correlation for seven out of eight validated
genes (Additional file 5: Table S4). The microarray and
qRT-PCR derived fold-changes were in a good agreement.
Subsequently, the differentially expressed genes were
subjected to pathway enrichment analyses in order to
determine pathways common or specific to the radioresis-
tant or radiosensitive phenotype. In total, 65 and 455
pathways were significantly enriched (FDR < 0.1) for the
SP and RP clone, respectively (Additional file 6: Table S5).
The top 100 identified pathways ordered according to the
highest matching (percentage of differentially expressed
genes of all genes in a pathway) were grouped into major
pathways (Table 1).
This resulted in a set of commonly deregulated path-
ways compared to the parental cell line but not specific
for a particular phenotype of radiation sensitivity. More-
over, pathways specific to the radiosensitive or radioresis-
tant phenotype were identified. These comprised mainly
pathways that are known to be affected by ionizing irra-
diation in HNSCC [36–38].
Integration of copy number changes with differentially
expressed genes
To verify whether the aberrant expression of genes in the
SP and RP subclones can be explained by the observed
copy number changes, integration of genomic (array CGH
data) and transcriptomic data was performed. For subclone
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Fig. 2 SKY results of the CAL-33 cell lines. The yellow arrows point the common for all CAL-33 cell lines marker chromosomes. The additional
chromosomal rearrangements in analyzed clones compared to the parental CAL-33 cells are marked with white arrows. Structural and numerical
aberrations in the parental CAL-33 cell line (a) involve chromosomes 3, 7, 8, 9 16, 18, 20, X, and Y. Aberrations of subclone SP (b) include chromosomes
2, 3, 7, 8, 9, 11, 16, 18, 20, 21, X, and Y. Chromosomal aberrations of subclone RP (c) affect chromosomes 1, 3, 4, 5, 7, 8, 9, 14, 16, 18, 20, X, and Y
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SP, we identified 18 genes with DNA gains being up-
regulated and 31 genes with DNA losses being down-
regulated, whereas for subclone RP, 44 up-regulated genes
showed copy number gains and 5 genes with copy number
losses were down-regulated (Table 2).
This integrative data analysis of DNA copy number and
gene expression followed by pathway enrichment analysis
allowed us to identify related pathways encompassing
signaling by Rho GTPases as one of the deregulated
pathways in the SP subclone. At the same time we
observed DNA loss and downregulation of the TIAM1
gene that belongs to the Rho GTPases signaling pathway.
Yang et al. recently showed that high expression of TIAM1
is associated with poor clinical outcome in patients with
HNSCC [39]. Similarly, for the RP subclone a gain and
upregulation of RAD1 and RICTOR genes was observed
which is in accordance with the deregulation of the
homologous recombination and PI3K signaling pathways in
Table 1 Significantly enriched pathways of genes differentially expressed in subclones SP and RP compared to the parental CAL-33
cells
CAL-33 SP vs parental Common signalling pathways CAL-33 RP vs parental
Transmembrane transport of small molecules Signaling by VEGF Nonhomologous end-joining (NHEJ)
GPCR ligand binding Extracellular matrix organization Homologous DNA pairing and strand exchange
Signaling by Rho GTPases RNA polymerase III transcription initiation CD28 dependent PI3K/Akt signaling
Interferon signaling NOTCH1 intracellular domain regulates
transcription
Signaling by interleukins
Senescence-associated secretory phenotype (SASP)
NOD1/2 signaling pathway
TNFR1-induced NFkB signaling pathway
Toll-like receptors cascades
Death receptor signaling
MAPK1/MAPK3 signaling
Pathways common (middle) and specific to the radiosensitive (left) or radioresistant (right) phenotype are shown. The corresponding genes and their direction of
regulation (up/down) are listed in Additional file 4: Table S3 and Additional file 6: Table S5
Fig. 3 Array CGH profiles of the CAL-33 cell lines. The array CGH profiles of all of the three cell lines show copy number alterations on several
chromosomes: (a) parental CAL-33 cell line, (b) subclone SP, (c) subclone RP. The green bars (starting from the top) represent DNA copy number
gains at the corresponding position in the genome, whereas the red bars (starting from the bottom) indicate DNA copy number losses. Bars reaching
beyond the middle axis (probability >0.5) were called as gains or losses
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HNSCC as previously described in [40]. For both of those
clones a gain and upregulation of the TLR4 gene and the
deregulation of the toll-like kinases signaling pathway in-
cluding upregulation of the genes PLCG2, TAB3, RPS6KA2
has been detected. Even though contradictory reports exist,
the overexpression of TLR4 and activation of related path-
way has been described to promote HNSCC tumor deve-
lopment and to ensure tumor protection from the immune
system [41].
Time-dependent gene expression in response to ionizing
radiation in CAL-33 clones
It was hypothesized that CAL-33 subclones with diffe-
rent phenotypes of radiosensitivity also show differences
in gene expression profiles in response to irradiation.
Therefore, we performed differential time-course micro-
array analyses between irradiated (8 Gy) and sham irra-
diated control cells. 7299, 6980, and 8111 genes were
differentially expressed in the CAL-33 parental, SP, and
RP subclones, respectively (Table 3). Although the num-
ber of differentially expressed genes after irradiation with
8 Gy was comparable for all cell lines studied, appro-
ximately 50 % of the affected genes were not identical.
More than 1000 genes were exclusively involved in the
radiation response of each of the CAL-33 cell clones
(Fig. 4). The entirety of differentially expressed genes in
response to ionizing radiation is listed and compared for
all CAL-33 cell lines in Additional file 7: Table S6.
To identify common and separate pathways of the
radiation response, pathway enrichment analyses were
Table 2 Integration of differentially expressed genes with array
CGH data
CAL-33 SP (#303) CAL-33 RP (#327)
Gene name FC Gene name FC
PTGS1 16.417 gain PTGS1 20.52 gain
TLR4 10.333 IL7R 10.643
SLC2A6 7.167 SLC2A6 7.13
TNC 5.478 SLC12A7 6.931
PHF11 4.886 COL5A1 6.608
PAPPA 4.594 CERCAM 6.381
MX2 4.457 PDZD2 5.726
LHFP 4.442 PTGER4 5.05
RGCC 4.285 STXBP1 4.377
GTF2F2 3.767 INPP5E 3.797
BACE2 3.755 NKD2 3.785
NEK3 3.564 SLC1A3 3.784
MSANTD3 3.198 RICTOR 3.675
FNDC3A 2.971 PTGES 3.409
RC3H2 2.77 MVB12B 3.381
INPP5E 2.584 CDK5RAP2 3.362
RPL7A 2.543 PRRC2B 3.155
UFM1 2.485 SEC16A 2.948
SLC25A29 0.263 loss RC3H2 2.855
RCOR1 0.297 USP20 2.714
HLCS 0.305 RPL7A 2.59
CCDC85C 0.318 CARD9 2.572
IPO5 0.322 TOR1B 2.529
WRB 0.326 TRAF1 2.524
PIGP 0.329 QSOX2 2.492
CDCA4 0.36 TLR4 2.473
ZBTB42 0.361 UGCG 2.463
EVA1C 0.37 ZBTB43 2.396
BTBD6 0.37 C9orf9 2.327
TTC3 0.374 RAD1 2.255
CLN5 0.388 TRIM32 2.241
CCNK 0.389 PTRH1 2.221
DSC3 0.389 CEP72 2.208
PPP1R13B 0.389 DAP 2.035
DYRK1A 0.393 C9orf114 2.019
SIVA1 0.4 SDHA 2.013
BRF1 0.404 DOLPP1 1.997
IMPACT 0.41 RALGPS1 1.996
IFNGR2 0.416 SURF1 1.958
TIAM1 0.423 MTRR 1.855
PCCA 0.426 C5orf42 1.849
EML1 0.432 ANKRD33B 0.609
Table 2 Integration of differentially expressed genes with array
CGH data (Continued)
HMGN1 0.439 OR4C6 0.576
SETD3 0.441 NPR3 0.43
OSBPL1A 0.462 GOLGA6L6 0.505 loss
IFNAR2 0.54 ZNF480 0.532
LAMA3 2.1 NBPF10 1.909
CRIP1 2.463 TPTE 2.342
CDH2 5.373 NBPF9 2.945
Detailed information on identified genes, their CNA status and corresponding
fold changes are presented
Table 3 Comparison of detected and differentially expressed
genes after irradiation for analyzed cell sublines
CAL-33 (8 Gy vs sham-irradiated) Parental
cell line
Subclone SP Subclone RP
Total number of detected genes 12529 12259 12714
Number of differentially
expressed genes
7299 6980 8111
Number of genes in the network 6256 5709 6859
5 % top genes 313 285 343
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performed on early and late responding genes, respec-
tively (Additional file 8: Table S7). The most interesting
pathways with regard to their known role in radiation
response were grouped in to major pathways (Table 4).
It is interesting to note that all cell lines share a set of
deregulated pathways (Table 4). In addition, for each of
the radiosensitivity phenotypes (parental, SP, RP) specific
pathways were observed. The early responses in gene
expression include interferon signaling and in particular
for the resistant phenotype the cellular response to hy-
poxia which is known for a long time to have a crucial role
in radioresistance [42, 43]. Also, some other pathways
from an early gene expression response that are involved
in DNA repair, cell cycle, cellular response to stress and
apoptosis impact on survival after irradiation and there-
fore contribute to radioresistance [9, 44–46].
Deregulated pathways related to late responding genes
include EGFR- and PI3K/AKT signaling that were already
linked to poor clinical outcome and therapy response in
HNSCC [47–49] in association with ERBB2, ERBB3 and
ERBB4 co-expression [50–52]. Interestingly, also involve-
ment of ERBB2 and EERB4 receptor signaling was observed
in all cell lines as a late response to ionizing radiation.
Further late responding pathways include toll-like receptor
cascades, interleukin signaling, NF-kB activation and inter-
feron signaling all of which are frequently detected after
treatment with ionizing radiation [53, 54]. However, the
role of interleukin signaling and immune response is largely
unknown so far. This also applies to cellular senescence
and the impact of senescence pathways on radioresistance
that were also discovered as late responding pathways in
our CAL-33 subclones. Although evidence exists that
senescence might be associated with the disruption of the
tissue microenvironment leading to the secretion of
senescence-associated pro-inflammatory factors and to the
development of a pro-oncogenic environment [34] its role
in radioresistance in rather unclear so far.
Gene association network reconstruction and network
analysis
To go beyond pathway enrichment analyses of differen-
tially expressed genes, gene association networks were
reconstructed. Parameters of the obtained networks
(provided as igraph R-objects in Additional file 9: File S1)
for all three CAL-33 cell lines are presented in Table 3.
Subsequently, the combined topological centrality mea-
sure was used to characterize the biological importance of
genes in the reconstructed association networks. We iden-
tified nodes (genes) that are likely to control the network
by combining three network centrality measures: degree,
Fig. 4 Venn diagram displaying commonly and exclusively differentially
expressed genes of each CAL-33 cell line after irradiation with 8 Gy
Table 4 Significantly enriched pathways of early and late
responding genes after ionizing radiation
Subclone SP CAL-33
parental
Subclone RP
Early and late
responding
pathways
Apoptosis
Cellular senescence
Cell cycle
Cellular responses to stress
Signaling by Wnt
Signaling by Rho GTPases
Early responding
pathways
DNA double-strand break repair
Signaling by
TGF-beta receptor
complex
Interferon
signaling
Cellular response
to hypoxia
TRAF6 mediated
NF-kB activation
Late responding
pathways
Signaling by TGF-beta receptor complex
TRAF6 mediated NF-kB activation
Interferon signaling
Toll-Like receptors cascades
Signaling by interleukins
Extracellular matrix organization
MAPK family signaling cascades
NOD1/2 signaling pathway
PI3K/AKT signaling in cancer
Signaling by VEGF
Signaling by EGFR
Signaling by FGFR
Signaling by NOTCH
Signaling by ERBB2
Signaling by ERBB4
GPCR ligand
binding
Base excision
repair
GPCR ligand
binding
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closeness and shortest path betweenness [32, 55]. The 5 %
of the highest ranked genes (listed in Additional file 10:
Table S8) were mapped to the Reactome pathways to
further evaluate their biological roles. The top ten pathways
according to the FDR values are listed in Table 5. All iden-
tified pathways are listed in Additional file 11: Table S9.
Two of the detected pathways, signaling by Rho GTPases
and signaling by Wnt, were in common for all three sub-
clones exposed to irradiation (Table 5). However, most of
the pathways were different for the individual subclones.
For the parental cell line, we additionally detected pathways
associated with cellular response to stress, signaling by
Table 5 The top pathways after mapping of 5 % highest ranked genes from the reconstructed gene association networks to the
Reactome pathways
Pathway Genes
CAL-33 parental Generic transcription pathway CCNC, NR4A3, ZNF248, ZNF302, ZNF350, ZNF417, ZNF431, ZNF543,
ZNF621, ZNF710, ZNF735
Cellular responses to stress BAG4, CDKN2D, DEDD2, GABARAPL2, HSPA1A, MAPK10, RBX1
Diseases of signal transduction CBL, CCNC, CTBP2, FOXO4, RBX1, TGFB1
EPH-ephrin mediated repulsion of cells CLTCL1, EFNA5, SRC
Neurotransmitter release cycle CHAT, SNAP25, STXBP1
O-linked glycosylation ADAMTSL5, CFP, ST3GAL3, THBS2
Signaling by EGFR CBL, FOXO4, NF1, PAG1, RBX1, SPRY1, SRC
Signaling by Wnt CTBP2, DAAM1, FRAT1, RAC2, RBBP5, RBX1, SOX3
Signaling by Rho GTPases ABR, CENPA, DAAM1, PKN3, RAC2, RANGAP1, SRC
Cytochrome P450 - arranged by substrate type CYP17A1, CYP3A4, CYP4A11
SP subclone Axon guidance APH1A, DPYSL3, HSP90AB1, ITGA9, LAMTOR2, NRG1, PLXNA4,
PPP2CA, PSPN, RAC1, RDX, RGMB
Generic transcription pathway AKT2, LAMTOR2, MED26, TBL1XR1, ZNF302, ZNF394, ZNF431,
ZNF561, ZNF680, ZNF691, ZNF750, ZNF774
Cell cycle CDKN2D, EP300, MASTL, MAU2, MCM4, NUPL2, PPP2CA, RAD21,
RANGAP1, SKA2, SYCP1
Chromatin organization ATXN7, EP300, HIST3H2A, KDM4D, KDM5D, SUPT20H, TBL1XR1
Diseases of signal transduction AKT2, APH1A, BCR, CTBP2, EP300, NRG1, PPP2CA, TBL1XR1
Signaling by Wnt AKT2, CCDC88C, CTBP2, EP300, PLCB1, PPP2CA, RAC1, RNF146
Semaphorin interactions DPYSL3, HSP90AB1, PLXNA4, RAC1
Glycolysis ALDOC, GCK, PPP2CA
Regulation of beta-cell development AKT2, GCK, IAPP
RHO GTPases activate WASPs and WAVEs NCKIPSD, RAC1, WAS
RP subclone Signaling by Rho GTPases ABR, ACTB, ARHGAP35, ARHGEF7, BCR, HIST1H2BJ, HIST1H2BL,
HIST2H2BE, INCENP, ITSN1, NDE1, OBSCN, RHOT1, SRGAP1, WAS
Cell Cycle ANAPC11, BLM, CDKN1A, CDKN2D, FZR1, HIST1H2BJ, HIST1H2BL,
HIST2H2BE, INCENP, KIF23, MAU2, NDE1, NUP62, POM121,
PSMC3IP, TK2, WHSC1
Senescence-associated secretory phenotype (SASP) ANAPC11, CDKN1A, CDKN2D, FZR1, HIST1H2BJ, HIST1H2BL, HIST2H2BE
GPCR ligand binding CCL19, GPR132, MC1R, MLN, OPN1SW, OPRL1, PTCH2, PTGDR,
PTGER1, TAS2R14, TAS2R19, TAS2R45, TBXA2R, WNT10B
Transcriptional regulation by small RNAs HIST1H2BJ, HIST1H2BL, HIST2H2BE, NUP62, POM121
G alpha (12/13) signaling events ABR, ARHGEF7, ITSN1, OBSCN, TBXA2R
Post-translational protein modification ADAMTS19, ARSB, ARSG, BLM, CFP, CNIH1, CNIH2, GALNT10, NUP62,
POM121, ST3GAL3
DNA repair ACTB, BLM, CHD1L, DTL, ERCC6, HIST1H2BJ, HIST1H2BL, HIST2H2BE,
WHSC1
Signaling by Wnt HIST1H2BJ, HIST1H2BL, HIST2H2BE, NFATC1, PLCB1, SOX3, TCF7L2,
TMED5, WNT10B
Assembly of the primary cilium BBS10, CC2D2A, NDE1, NPHP1, PDE6D, TCTEX1D2, TTC30B
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EGFR, and cytochrome P450. The most important path-
ways in the SP subclone were associated with axon gui-
dance, chromatin organization and semaphorin, whereas
for the RP subclone the senescence-associated secretory
phenotype (SASP) together with GPCR ligand binding
were considered as crucial. The co-occurrence of the
SASP and GPCR signaling pathways, that are known
to be connected [56], indicate that the identification of
those pathways might not be accidental and suggest a
high importance for the radiation resistant phenotype.
In future experiments more HNSCC cell lines should
be analyzed.
Fig. 5 First neighborhood of the ERV3-1 gene extracted from the reconstructed gene association networks
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Expression of endogenous retrovirus and related
pathways
The analysis of differentially expressed genes between the
RP and SP subclones and the parental cell line revealed
the ERVMER34-1 gene as differentially expressed in both
clones. Approximately 8 % of the human genome consists
of endogenous retroviruses (ERVs) that have been derived
from exogenous retroviruses following infection and
DNA integration into germ line cells [57, 58]. Although
most of the ERV sequences have defective structures,
some of ERV genes still have an open reading frame
(ORF) and protein expression [59]. ERV genes can pro-
mote homologous and non-homologous recombination
and therefore, may introduce new mutations [60, 61].
Furthermore, ERVs may lead to genome instability, and
contribute to tumor initiation and progression [62]. The
expression of ERV genes has been demonstrated in vari-
ous cancers, including breast, ovarian, prostate and mel-
anoma [63–66]. The differential gene expression analyses
of the subclones in comparison to the parental CAL-33
cells revealed ERVMER34-1 gene as differentially expressed
in both derived clones (Additional file 4: Table S3). Subse-
quently, we tested whether any of the retroviral genes were
differentially expressed in response to ionizing radiation.
Apart from ERVMER34-1, we were able to identify another
endogenous retroviral gene, ERV3-1, that was temporally
differentially expressed following radiation. The time
dependent expression of those genes suggests ERV3-1 ex-
pression to be associated with the radiation response,
whereas ERVMER34-1 expression exhibits rather random
fluctuations (Additional file 12: Figure S2 and Additional
file 13: Figure S3). Thus, the ERV3-1 expression clearly
implies a possible association with the radiation exposure.
The radiation-associated upregulation of ERV3-1 is dem-
onstrated for all subclones starting from the second day of
irradiation. To our knowledge, the expression of ERV3-1
following radiation and its influence on radiation resistance
has not been addressed in detail so far. A recent study by
Lee et al. [67] has demonstrated an increase in the expres-
sion of ERV3-1 (HERV-R) env related to a fractionated
exposure to γ-radiation in radioresistant A549 lung cancer
cells but not in less radioresistant H460 cells. The presented
results raise the question whether overexpression of ERV3-
1 might be involved in the radiation response of HNSCC
cells. To gain knowledge about the potential gene interac-
tions with the ERV3-1 gene we used the gene association
networks reconstructed for all CAL-33 subclones and
extracted the putative direct or indirect ERV3-1 interaction
partners resulting in the first neighborhood genes of ERV3-
1 differ between the three analyzed cell lines (Fig. 5). The
largest first neighborhood gene association network can be
observed for the RP subclone where 29 genes are linked to
ERV3-1. For the CAL-33 parental cell line and the SP
subclone the first neighborhood gene association network
consist only of three (OR2A2, U2AF1L4, C11orf94) and
one (FEEH2) potential association partners, respectively.
The considerably larger first neighborhood of the ERV3-1
gene for the RP cells suggests a more important role of this
gene for acquired radiation resistance. In addition, a Reac-
tome pathway enrichment analysis revealed that the first
neighborhood genes of the ERV3-1 gene in RP cells were
associated with GPCR signaling (DRD4, OPN1MW, TBX
A2R), transmembrane transport of small molecules (ATP
1B2, AZGP1, SLC22A17), generic transcription pathway
(ZNF419, ZNF550, ZNF782), signaling by Rho GTPases
(NCKIPSD), and cell cycle (MAX). However, to our know-
ledge, the interaction partners of the ERV3-1 gene have not
been studied in detail so far, which makes an interpretation
difficult and highly speculative at this time. Also further
studies have to be performed in order to validate the gene
associations with ERV3-1independently.
Conclusion
In conclusion, the present study presents comprehensive
gene expression data of CAL-33 subclones of different
radiosensitivity. Based on these data networks have been
identified that are linked to the radiation response
phenotypes. The pathways associated with the resistant
phenotype are of special interest focusing on the
senescence-associated secretory phenotype (SASP) to-
gether and GPCR ligand binding. Also, the radiation-
associated expression of the endogenous retrovirus
ERV3-1 appears highly attractive for further studies on
the molecular mechanisms of acquired radioresistance.
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Conclusion and outlook
The aim of this cumulative thesis was the establishment of a biostatistical method for
the analysis of longitudinal gene expression data and the application of this method
for the identification of signaling pathways involved in the radiation responses of
1) normal lymphoblastoid cells differing in their radiation sensitivity and 2) tumor
HNSCC cells differing in their radiation resistance.
Several different algorithms have been suggested to analyze time-course transcrip-
tomic data with regard to differential expression between treatment groups [121–
124]. However, all those methods suffer from different limitations from which the
need for relatively high number of measured data points and the demand for in-
clusion of biological and/or technical replicates are the most disadvantageous. The
natural cubic spline regression method for the detection of temporally differentially
expressed genes presented within this thesis does not require any replicates and ad-
ditionally allows for the adaptation of the applied spline models depending on the
number of collected data points. Moreover, the proposed algorithm does not need
identical sampling times for the compared treatments groups, which for the majority
of methods is compulsory. The introduced method can be applied also on incom-
plete time-course data sets, what is especially important for studies with limited
sample source where for technical reasons some samples had to be excluded and
cannot be repeatedly generated. Therefore, the method is useful and applicable also
to data that were not particularly generated for time-course gene expression studies
including already existing data sets from clinical samples. Re-analysis of previously
generated time-course data often allows to address new clinical questions and find
new important values to the existing data.
To ensure the access of the proposed method for other users and future applications,
I have implemented, described and provided the biostatistical approach developed
within this thesis as an R software package "splineTimeR" which is freely available
via the Bioconductor project at https://www.bioconductor.org [125].
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The performance of the approach introduced within this thesis has been compared
and validated with another established method for the temporal gene expression data
analysis called BETR that has shown the best performance over other commonly
used methods [126]. Both compared methods detected the same biological processes
as the most important with regard to the radiation response in normal cells as pre-
sented in the first publication, thereby proving the plausibility of the spline-based
method. However, the spline method was able to detect more differentially expressed
genes than the BETR method, which was shown to detect only 65% of truly differ-
entially expressed genes [126]. Therefore, the proposed spline-based method allows
achieving higher identification rates of temporally differentially expressed genes.
In the first study (publication I), the application of the spline differential expres-
sion method in combination with network reconstruction and pathway enrichment
analyses provided insight into the mechanisms that might be relevant for the acute
radiation response of normal cells. The obtained results revealed the impact of
senescence-associated pathways and raised the question about the influence of senes-
cent cells on radiotherapy outcome. Future experiments using clinical samples have
to evaluate the role of senescence in acute radiation response of tumor surrounding
normal tissues.
In the second study (publication II), the proposed data analysis workflow has been
used to identify pathways that may have an important impact on radioresistance of
HNSCC cancer cells. Senescence-associated secretory phenotype (SASP) and GPCR
ligand binding were the most important and significantly deregulated signaling path-
ways identified for the resistant phenotype after exposure to ionizing radiation. The
co-occurrence of the SASP and GPCR signaling pathway, that are known to inter-
play [127], implies that the identification of those pathways might not be coincidental
and suggests a high importance for the radiation resistant phenotype. However, this
hypothesis has to be validated in subsequent studies with clinical data.
This thesis represents a statistical effort to elucidate the molecular mechanisms of
the radiation responses of therapeutically relevant cells. Mathematical modeling of
biological or clinical data has a potential to be beneficial in therapy treatment plan-
ning. The mathematical models may help to understand the underlying molecular
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processes and to predict the success of new treatment strategies. In silico model-
ing of radiation response is emerging as an important tool for treatment simula-
tions, outcome predictions and therapy optimization, which can contribute to the
improvement of the therapy treatment. There is a particular need for modeling of
the identified pathways from this thesis by perturbation experiments as already ex-
emplified by Klinger et al. for EGFR-related pathways in colon cancer cell lines [87].
Interdisciplinary research leading to predictive models not only of radiation response
by implementing biostatistical techniques needs to be encouraged to enable further
developments in the clinical diagnostics and sophisticated treatment planning.
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